var title_f31_7_31856="Acyclovir: Drug information";
var content_f31_7_31856=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Acyclovir: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12618184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12618185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/40/37512?source=see_link\">",
"       Acyclovir (systemic): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/27/1460?source=see_link\">",
"       Acyclovir (topical): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9335 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31856=[""].join("\n");
var outline_f31_7_31856=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?36/40/37512?source=related_link\">",
"      Acyclovir (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/27/1460?source=related_link\">",
"      Acyclovir (topical): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_7_31857="PBC palmar xanthomas";
var content_f31_7_31857=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F51686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F51686&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    PBC palmar xanthomas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Palmar xanthomas from primay biliary cirrhosis, rarely seen today.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31857=[""].join("\n");
var outline_f31_7_31857=null;
var title_f31_7_31858="Scalpels";
var content_f31_7_31858=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F71823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F71823&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Scalpel blades",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 266px; height: 508px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A: types of blades; Panel B: the angled scalpel is useful in performing cervical conization.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31858=[""].join("\n");
var outline_f31_7_31858=null;
var title_f31_7_31859="Deinfibulation 3";
var content_f31_7_31859=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79801&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Deinfibulation 3",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Step 3: Incision to, but not into, clitoris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31859=[""].join("\n");
var outline_f31_7_31859=null;
var title_f31_7_31860="EEG Wicket spikes";
var content_f31_7_31860=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F78379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F78379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Wicket spikes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 283px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    These may appear in clusters or singly in the temporal regions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drs. Lawrence Hirsch and Hiba Arif.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31860=[""].join("\n");
var outline_f31_7_31860=null;
var title_f31_7_31861="Prenatal ultrasound bilateral MCDK";
var content_f31_7_31861=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F79332%7EOBGYN%2F80361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F79332%7EOBGYN%2F80361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound of bilateral multicystic dysplastic kidneys showing the circumferential arrangement of the cysts",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Follow-up ultrasound examination of this pregnancy in the third trimester revealed anyhydramnios and reduction in size of both kidneys.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tulin Ozcan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound of unilateral multicystic dysplastic kidney",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 416px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Tulin Ozcan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31861=[""].join("\n");
var outline_f31_7_31861=null;
var title_f31_7_31862="Colon polyp piecemeal excision";
var content_f31_7_31862=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F87246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F87246&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Colon adenoma removed with piecemeal excision",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 407px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Colon adenoma seen in blue light (narrow band imaging). The use of blue light enhances differences between polyp and normal mucosa.",
"    <br/>",
"    (B) After piecemeal resection, small areas of possible remnant tissue can be seen (arrows).",
"    <br/>",
"    (C) Endoscopic image following selective treatment of residual tissue with argon plasma coagulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31862=[""].join("\n");
var outline_f31_7_31862=null;
var title_f31_7_31863="Assessment of neonatal pain";
var content_f31_7_31863=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Assessment of neonatal pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31863/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31863/contributors\">",
"     KJS Anand, MBBS, DPhil, FAAP, FCCM, FRCPCH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31863/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31863/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31863/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31863/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/7/31863/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 24, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonatal discomfort, stress, or pain may be associated with routine patient care (eg, physical examination and diaper changes), moderately invasive care measures (eg, suctioning, phlebotomy, and peripheral intravenous line placement), or more invasive procedures (eg, chest tube placement and circumcision).",
"   </p>",
"   <p>",
"    Pain in the neonate can be classified into three categories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute or physiological pain occurs from skin-breaking procedures or tissue injury caused by diagnostic or therapeutic interventions. Infants admitted to the neonatal intensive care unit (NICU) repeatedly experience acute pain from an average of 12 to 16 invasive procedures each day [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/2,3\">",
"       2,3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Established pain occurs following surgery, or localized inflammatory conditions (eg, abcess or thrombophlebitis), or birth-related trauma.",
"     </li>",
"     <li>",
"      Prolonged pain results from severe diseases like necrotizing enterocolitis or meningitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Care providers are expected to prevent any infant from experiencing pain if at all possible [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Pain assessment is a necessary part of neonatal pain management, as an indication for initiating therapy as well as assessing its effectiveness. It is challenging to detect and measure the intensity of pain in neonates because of their inability to communicate with care providers.",
"   </p>",
"   <p>",
"    The need for effective pain management and the assessment of pain in neonates will be reviewed here. Prevention and treatment of neonatal pain are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=see_link\">",
"     \"Prevention and treatment of neonatal pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;This topic review uses the following terms as defined by the neonatal pain-control group of the Newborn Drug Development Initiative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain &ndash; An unpleasant somatic or visceral sensation associated with actual or potential tissue damage.",
"     </li>",
"     <li>",
"      Stress &ndash; A disturbance of the dynamic equilibrium between an infant and",
"      <span class=\"nowrap\">",
"       his/her",
"      </span>",
"      environment that results in a physiologic response by the infant.",
"     </li>",
"     <li>",
"      Stress or pain response &ndash; The individual's physiologic response to perceived stress or pain that is characterized primarily by changes in four domains (ie, endocrine, autonomic, immunologic,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      behavioral responses).",
"     </li>",
"     <li>",
"      Analgesia &ndash; Absence or reduction of pain in the presence of stimuli that would normally be painful.",
"     </li>",
"     <li>",
"      Pain control &ndash; Reduction in the intensity",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      duration of pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, pain prevention and control have been underutilized in neonates because of the following",
"    <strong>",
"     misconceptions",
"    </strong>",
"    :",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Their pain pathways are unmyelinated or otherwise immature and cannot transmit painful stimuli to the brain.",
"     </li>",
"     <li>",
"      There is no alternative for verbal self-report, which is touted as the \"gold standard\" for conveying a subjective experience like pain.",
"     </li>",
"     <li>",
"      Pain perception is located only in the cortex and thalamocortical connections must be fully developed in order to allow pain perception.",
"     </li>",
"     <li>",
"      The human infant does not have the psychological context in order to identify any experiences as painful and this does not develop until two years or later.",
"     </li>",
"     <li>",
"      Newborn infants are at greater risk for developing the adverse effects of analgesic or sedative agents, or these drugs have adverse long-term effects on brain development and behavior.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, not one of these misconceptions is supported by the current evidence. Beginning in the 1980s, accumulating evidence demonstrated that both preterm and term infants experience pain and stress in response to noxious stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. By the middle of the second trimester, the human fetus has a highly differentiated and fully functional sensory system [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Optical neuroimaging studies show increased cortical activation in the somatosensory areas of the brain in preterm infants exposed to painful stimuli (eg, heel stick or venipuncture) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Numerous studies have documented neonatal responses to pain, which include autonomic (eg, increases in heart rate, blood pressure), hormonal (eg, cortisol and catecholamine responses), and behavioral changes (eg, facial grimace) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/8,16-20\">",
"     8,16-20",
"    </a>",
"    ]. These responses form the basis of the many pain assessment tools used to evaluate acute pain in the neonate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/17,21-24\">",
"     17,21-24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Assessment of pain'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Frequency of painful procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Painful procedures are common in neonates, especially those in the NICU. Analgesic therapy is often not given, despite greater understanding that neonates experience pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/2,3,25\">",
"     2,3,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The prevalence of untreated neonatal pain was best illustrated by a large prospective French study of 430 neonates admitted to tertiary NICUs during a six-week time period beginning in September 2005 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/3\">",
"     3",
"    </a>",
"    ]. All painful and stressful procedures were recorded for each participant during the first 14 days following NICU admission. The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overall, almost 70,000 first-attempt procedures were recorded, of which 70 percent were painful and 30 percent were stressful. An additional 11,500 supplemental attempts were performed, of which 90 percent were painful and 10 percent were stressful.",
"     </li>",
"     <li>",
"      Neonates experienced a median of 115 procedures during the 14-day study period, of which 75 were painful.",
"     </li>",
"     <li>",
"      Of the 42,413 painful procedures, specific analgesic therapy for the therapy was provided in 20.8 percent of patients, which included only nonpharmacologic therapy (18 percent), only pharmacologic therapy (2 percent), and both nonpharmacologic and pharmacologic therapy (0.4 percent). An additional 34 percent of patients were receiving concurrent analgesia or anesthetic therapy for other reasons during the procedure.",
"     </li>",
"     <li>",
"      Factors associated with greater use of specific preprocedural analgesia included prematurity, the type of procedure, parental presence, surgery, daytime, and day of procedure after the first day of admission. In contrast, mechanical and noninvasive ventilation and use of concurrent analgesia were associated with lower use of specific preprocedural analgesia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Effects of inadequately treated pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accumulating data suggest that untreated or inadequately treated neonatal pain may have long-term deleterious effects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Several studies have reported that repeated episodes of pain alter subsequent pain sensitivity and reactivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. For example, infants of diabetic mothers, who were exposed to repeated heel sticks just after birth, exhibited more intense pain responses (facial grimacing and crying) during later venipuncture compared to normal infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/29\">",
"     29",
"    </a>",
"    ]. Infants exposed to circumcision pain at birth experienced greater pain at immunization four to six months later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/32\">",
"     32",
"    </a>",
"    ], whereas those exposed to gastric suctioning at birth evidenced three-fold greater odds of developing irritable bowel syndrome during adolescence or adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/33\">",
"     33",
"    </a>",
"    ]. Adolescents born prematurely also display higher somatic pain sensitivity than adolescents born at term [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/34\">",
"     34",
"    </a>",
"    ]. These findings and other animal studies substantiate the theory that repeated exposure to neonatal pain leads to permanent changes in pain processing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neuroanatomical and behavioral changes have also been reported in adult animals that were exposed to neonatal pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. In one study, exposure to persistent hind paw pain in newborn rats induced changes in primary afferent neurons and their spinal neuronal circuits in adult animals, both at baseline and following sensory stimulation, compared to control animals [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/36\">",
"     36",
"    </a>",
"    ]. Another study showed that the neuroanatomical and behavioral changes following repetitive inflammatory pain resulted from neuronal excitotoxicity, which was ameliorated by",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?39/18/40229?source=see_link\">",
"     ketamine",
"    </a>",
"    analgesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/39\">",
"     39",
"    </a>",
"    ]. It remains unclear whether such long-term effects will occur in adult humans exposed to prolonged pain as neonates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/26,40,41\">",
"     26,40,41",
"    </a>",
"    ]. It is increasingly recognized, however, that exposure to repetitive pain in early life may expose patients to greater risks of developing increased pain sensitivity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    chronic pain syndromes during their subsequent lifespan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/42-47\">",
"     42-47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Interventions that reduce neonatal stress also improve clinical outcomes. In infants that underwent surgery, those who received greater amounts of anesthesia and analgesia compared to controls had reduced levels of norepinephrine, epinephrine, glucagon, aldosterone, and cortisol, decreased postoperative morbidity (eg, sepsis, metabolic acidosis, disseminated intravascular coagulation), and a lower mortality rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/16,48\">",
"     16,48",
"    </a>",
"    ]. Subsequent trials have confirmed the findings of improved clinical outcomes following anesthetic reduction of surgical stress.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     SYSTEMATIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The increased appreciation that neonates experience pain, the frequency of painful procedures they endure, and the effects of unrelieved pain have led to efforts to improve pain control in neonates.",
"   </p>",
"   <p>",
"    In 2006, the American Academy of Pediatrics and the Canadian Paediatric Society published new guidelines recommending that each health care facility that treats neonates establish a neonatal pain control program [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=see_link\">",
"     \"Prevention and treatment of neonatal pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These recommendations included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Routine assessment for the detection of pain",
"     </li>",
"     <li>",
"      Reduction of the number of painful procedures",
"     </li>",
"     <li>",
"      Guidelines and protocols to",
"      <span class=\"nowrap\">",
"       prevent/reduce",
"      </span>",
"      pain from invasive bedside procedures (eg, chest tube placement) or following surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A multicenter, observational study found that postoperative pain assessments by physicians increased the odds of receiving analgesia four-fold as opposed to those not assessed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/49\">",
"     49",
"    </a>",
"    ], thus highlighting the importance of pain assessment as a component of routine clinical evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ASSESSMENT OF PAIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Accurate pain assessments in the neonate remain challenging because of the inability of the infant to self-report. Since pain assessment is an essential prerequisite for optimal pain management, several scoring tools have been developed for this purpose.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pain assessment tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Available methods for neonatal pain assessment are either unidimensional (evaluate one parameter) or multidimensional (include physiologic, behavioral, and contextual parameters) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/1,4,50,51\">",
"     1,4,50,51",
"    </a>",
"    ]. Several multidimensional assessment tools with demonstrated validity, reliability, and clinical utility are currently used in the NICU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/17,21-24,49-54\">",
"     17,21-24,49-54",
"    </a>",
"    ]. These tools are based upon the following physiologic and behavioral indicators readily assessed at the bedside.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physiologic parameters - Changes in heart rate, respiratory pattern, blood pressure, and oxygen saturation.",
"     </li>",
"     <li>",
"      Behavioral responses - Crying, changes in facial expressions and body movements. In infants, total facial activity and cluster of specific facial findings (brow bulge, eye squeeze, nasolabial furrow, and open mouth) are associated with acute and postoperative pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/17,21-24,52,54\">",
"       17,21-24,52,54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The tools most commonly used in the NICU for acute pain assessment include the following (",
"    <a class=\"graphic graphic_table graphicRef80078 \" href=\"mobipreview.htm?16/34/16940\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      PIPP &ndash; Premature Infant Pain Profile [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      N-PASS &ndash; Neonatal Pain Agitation and Sedation Scale [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/55\">",
"       55",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      NIPS &ndash; Neonatal Infant Pain Scale [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/56\">",
"       56",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      CRIES &ndash; Crying, Requires Oxygen Saturation, Increased Vital Signs, Expression, Sleeplessness [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/23\">",
"       23",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Premature infants, the most likely group to undergo painful procedures, are less likely to consistently demonstrate the responses to pain selected by these assessment tools [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/18,52,57-59\">",
"     18,52,57-59",
"    </a>",
"    ]. These scales have been evaluated for acute pain and some for postoperative pain, but none of these methods assess persistent pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two multicenter studies illustrate that there is a wide range of pain assessment tools used in NICUs.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first study, 12 sites evaluated by the 2002 Neonatal Intensive Care Quality Improvement Collaborative used five different assessment tools [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the second study from the Child Health Accountability Initiative, 10 sites used eight different assessment tools [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Limitations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inability to select a single assessment tool is based in part upon the following limitations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/60\">",
"     60",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most tools were developed and validated for neonates undergoing acute pain (eg, venipuncture, heel stick).",
"     </li>",
"     <li>",
"      Many of the signs used in these assessment tools require the subjective evaluation by observers. As a result, there is significant interobserver variability in the evaluation of behavioral responses that can be reduced with multidisciplinary training of the staff [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/61,62\">",
"       61,62",
"      </a>",
"      ] .",
"     </li>",
"     <li>",
"      Some parameters may require specialized equipment at the bedside (eg, heart rate variability, palmar skin conductance).",
"     </li>",
"     <li>",
"      Some measures are not available in real-time to be clinically useful (eg, serum or salivary cortisol levels).",
"     </li>",
"     <li>",
"      Responses to pain may be decreased in neurologically impaired neonates [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/56,59\">",
"       56,59",
"      </a>",
"      ] and absent in those who receive paralytic medications.",
"     </li>",
"     <li>",
"      Tools for the assessment of persistent or prolonged pain in neonates (due to major surgery, osteomyelitis or necrotizing enterocolitis) have not been developed or completely validated [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/55,63\">",
"       55,63",
"      </a>",
"      ]. During episodes of persistent pain, neonates may enter a passive state, with limited or no body movements, an expressionless face, reduced variability in heart rate and respiratory rate, and decreased oxygen consumption [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/4,60\">",
"       4,60",
"      </a>",
"      ]. Thus, assessment tools based on these indicators will not adequately detect and assess the intensity of prolonged neonatal pain [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/57,60\">",
"       57,60",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based upon these observations, universal application of one of these assessment tools is not advisable. The choice of the assessment pain tool is dependent upon the neonatal population to be assessed and the different types of pain that need to be evaluated.",
"   </p>",
"   <p>",
"    In addition, behavioral responses are dependent on the subjective judgement of care providers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/60\">",
"     60",
"    </a>",
"    ]. Significant interobserver variability can be reduced but not entirely eliminated by training or greater experience. Clinicians performing pain assessments must also recognize potentially important relationships between the infant&rsquo;s pain expression, and the behavior including sensitivity and receptivity of the infant&rsquo;s care providers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Current efforts to improve the objectivity and accuracy of assessment tools include the use of neuroimaging and neurophysiologic techniques to measure brain activity as a means of validating pain scales for both acute and chronic pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/14,15,60\">",
"     14,15,60",
"    </a>",
"    ]. The goal is to provide the clinician a reliable and accurate method to detect pain and to quantify its intensity with ease at the bedside [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of our limited ability to detect and quantify pain in neonates, especially preterm infants, we suggest that pain control measures be administered preemptively to prevent or reduce pain due to known noxious stimuli [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/25,65\">",
"     25,65",
"    </a>",
"    ]. As a general rule, anything that causes pain in adults or older children will also cause pain in neonates, regardless of their gestational age. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=see_link\">",
"     \"Prevention and treatment of neonatal pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Staff training",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staff recognition of neonatal pain will determine whether or not neonates receive adequate pain control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/49,66\">",
"     49,66",
"    </a>",
"    ]. In a multicenter observational study, the documentation of physician pain assessment was the only significant factor associated with the use of pharmacologic analgesia after surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/49\">",
"     49",
"    </a>",
"    ]. In contrast, the type of surgery (major or minor) was not associated with the administration of pharmacologic therapy. Thus, each facility that cares for infants should adopt an assessment strategy for the detection and documentation of pain.",
"   </p>",
"   <p>",
"    Institution of a pain management program increases the awareness of the staff that pain occurs routinely in the NICU [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/49,62,66\">",
"     49,62,66",
"    </a>",
"    ] and that its control is an important clinical goal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. The effective use of a clinical assessment tool requires mandatory training of the staff to improve interobserver reliability and to educate the staff on the limitations of the selected tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;At our institution, we assess pain at least every four hours when vital signs are measured, and after each painful or therapeutic intervention. We use the PIPP (Premature Infant Pain Profile) for assessment of acute or postoperative pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/21,54\">",
"     21,54",
"    </a>",
"    ] and the N-PASS (Neonatal Pain Agitation and Sedation Scale) for the assessment of prolonged pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/55\">",
"     55",
"    </a>",
"    ]. We also utilize various contextual factors, and other behavioral or physiological indicators suggesting inadequate analgesia (eg, pupillary dilation). If parents are available, we ask for their opinion: do they feel that their baby is in pain? For prolonged pain in neonates, we should also consider the utility of EDIN (Echelle Douleur Inconfort Nouveau-Ne) as a clinical tool [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/67\">",
"     67",
"    </a>",
"    ] and the use of a device that measures neonatal stress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31863/abstract/68,69\">",
"     68,69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Neonates experience pain from the same interventions or clinical conditions as older children and adults. Infants who are cared for in the neonatal intensive care unit (NICU) may experience pain routinely, randomly, frequently, and for prolonged periods of time. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Frequency of painful procedures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Untreated or inadequately treated neonatal pain may have immediate and long-term effects including altered pain sensitivity and reactivity, and other adverse health outcomes. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Effects of inadequately treated pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Each health care facility that treats neonates should establish a neonatal pain control program that incorporates:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Standardized methods for the routine assessment of pain by physicians and nurses.",
"     </li>",
"     <li>",
"      Reduction of the number of painful procedures and physical handling. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=see_link&amp;anchor=H4#H4\">",
"       \"Prevention and treatment of neonatal pain\", section on 'Reduction of painful events'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Guidelines and protocols to treat acute and prolonged pain due to neonatal diseases, invasive procedures, or other aspects of NICU care. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=see_link\">",
"       \"Prevention and treatment of neonatal pain\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assessment of neonatal pain is challenging because of the inability of the infant to communicate with care providers. Assessment tools based on contextual factors, physiologic, and behavioral indicators have been developed to detect and measure the intensity of neonatal pain (",
"      <a class=\"graphic graphic_table graphicRef80078 \" href=\"mobipreview.htm?16/34/16940\">",
"       table 1",
"      </a>",
"      ). The most commonly used tools include multiple indicators and have demonstrated validity, reliability, and clinical utility. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Pain assessment tools'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A single assessment tool has not been adopted universally because each tool was developed and validated for selected populations and clinical settings. Most assessment tools may not detect prolonged pain, pain in extremely low birth weight premature infants (birthweight below 1000 g), or those receiving paralytic medications. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Pain assessment tools'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite the limitations of currently available tools, we recommend that each facility that cares for infants should adopt an assessment strategy for the detection of pain. A systematic approach increases the awareness of the clinical staff that pain is a pervasive finding in the NICU. Increased staff awareness may improve neonatal pain control (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Pain assessment tools'",
"      </a>",
"      above).",
"      <br/>",
"      <br/>",
"      In our practice, we use PIPP (Premature Infant Pain Profile) for assessment of acute or postoperative pain and the N-PASS (Neonatal Pain Agitation and Sedation Scale) for the assessment of prolonged pain. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Our approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because of the limited ability to detect and quantify neonatal pain, we recommend that pain control measures should be administered to prevent or reduce pain due to known noxious stimuli (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=see_link\">",
"       \"Prevention and treatment of neonatal pain\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/1\">",
"      Anand KJ, Aranda JV, Berde CB, et al. Analgesia and anesthesia for neonates: study design and ethical issues. Clin Ther 2005; 27:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/2\">",
"      Simons SH, van Dijk M, Anand KS, et al. Do we still hurt newborn babies? A prospective study of procedural pain and analgesia in neonates. Arch Pediatr Adolesc Med 2003; 157:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/3\">",
"      Carbajal R, Rousset A, Danan C, et al. Epidemiology and treatment of painful procedures in neonates in intensive care units. JAMA 2008; 300:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/4\">",
"      American Academy of Pediatrics Committee on Fetus and Newborn, American Academy of Pediatrics Section on Surgery, Canadian Paediatric Society Fetus and Newborn Committee, et al. Prevention and management of pain in the neonate: an update. Pediatrics 2006; 118:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/5\">",
"      Franck LS, Allen A, Cox S, Winter I. Parents' views about infant pain in neonatal intensive care. Clin J Pain 2005; 21:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/6\">",
"      Franck LS, Cox S, Allen A, Winter I. Parental concern and distress about infant pain. Arch Dis Child Fetal Neonatal Ed 2004; 89:F71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/7\">",
"      Anand KJ, Aranda JV, Berde CB, et al. Summary proceedings from the neonatal pain-control group. Pediatrics 2006; 117:S9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/8\">",
"      Anand KJ, Hickey PR. Pain and its effects in the human neonate and fetus. N Engl J Med 1987; 317:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/9\">",
"      Anand KJ, Brown MJ, Causon RC, et al. Can the human neonate mount an endocrine and metabolic response to surgery? J Pediatr Surg 1985; 20:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/10\">",
"      Andrews K, Fitzgerald M. Cutaneous flexion reflex in human neonates: a quantitative study of threshold and stimulus-response characteristics after single and repeated stimuli. Dev Med Child Neurol 1999; 41:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/11\">",
"      Lowery CL, Hardman MP, Manning N, et al. Neurodevelopmental changes of fetal pain. Semin Perinatol 2007; 31:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/12\">",
"      Anand, KJS. Fetal pain? Pain-Clinical Updates 2006; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/13\">",
"      Anand KJ, Maze M. Fetuses, fentanyl, and the stress response: signals from the beginnings of pain? Anesthesiology 2001; 95:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/14\">",
"      Slater R, Cantarella A, Gallella S, et al. Cortical pain responses in human infants. J Neurosci 2006; 26:3662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/15\">",
"      Bartocci M, Bergqvist LL, Lagercrantz H, Anand KJ. Pain activates cortical areas in the preterm newborn brain. Pain 2006; 122:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/16\">",
"      Anand KJ, Sippell WG, Aynsley-Green A. Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress response. Lancet 1987; 1:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/17\">",
"      Craig KD, Whitfield MF, Grunau RV, et al. Pain in the preterm neonate: behavioural and physiological indices. Pain 1993; 52:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/18\">",
"      Porter FL, Wolf CM, Miller JP. Procedural pain in newborn infants: the influence of intensity and development. Pediatrics 1999; 104:e13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/19\">",
"      Guinsburg R, Kopelman BI, Anand KJ, et al. Physiological, hormonal, and behavioral responses to a single fentanyl dose in intubated and ventilated preterm neonates. J Pediatr 1998; 132:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/20\">",
"      Johnston CC, Strada ME. Acute pain response in infants: a multidimensional description. Pain 1986; 24:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/21\">",
"      Stevens B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile: development and initial validation. Clin J Pain 1996; 12:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/22\">",
"      Ballantyne M, Stevens B, McAllister M, et al. Validation of the premature infant pain profile in the clinical setting. Clin J Pain 1999; 15:297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/23\">",
"      Krechel SW, Bildner J. CRIES: a new neonatal postoperative pain measurement score. Initial testing of validity and reliability. Paediatr Anaesth 1995; 5:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/24\">",
"      Holsti L, Grunau RE, Oberlander TF, et al. Body movements: an important additional factor in discriminating pain from stress in preterm infants. Clin J Pain 2005; 21:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/25\">",
"      Sharek PJ, Powers R, Koehn A, Anand KJ. Evaluation and development of potentially better practices to improve pain management of neonates. Pediatrics 2006; 118 Suppl 2:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/26\">",
"      Fitzgerald M. The development of nociceptive circuits. Nat Rev Neurosci 2005; 6:507.",
"     </a>",
"    </li>",
"    <li>",
"     Anand, KJS, Bhutta, AT, Hall, RW. Long-term effects of repetitive pain in the neonatal period: neuronal vulnerability, imprinting, and plasticity. In: Perinatal programming: Early Life Determinants of Adult Health and Disease. Hodgson, DM, Coe, C, eds. Taylor &amp; Francis Medical Books, London 2006. p. 197.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/28\">",
"      Grunau RE, Oberlander TF, Whitfield MF, et al. Demographic and therapeutic determinants of pain reactivity in very low birth weight neonates at 32 Weeks' postconceptional Age. Pediatrics 2001; 107:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/29\">",
"      Taddio A, Shah V, Gilbert-MacLeod C, Katz J. Conditioning and hyperalgesia in newborns exposed to repeated heel lances. JAMA 2002; 288:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/30\">",
"      Peters JW, Schouw R, Anand KJ, et al. Does neonatal surgery lead to increased pain sensitivity in later childhood? Pain 2005; 114:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/31\">",
"      Grunau RE, Holsti L, Haley DW, et al. Neonatal procedural pain exposure predicts lower cortisol and behavioral reactivity in preterm infants in the NICU. Pain 2005; 113:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/32\">",
"      Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal circumcision on pain response during subsequent routine vaccination. Lancet 1997; 349:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/33\">",
"      Anand KJ, Runeson B, Jacobson B. Gastric suction at birth associated with long-term risk for functional intestinal disorders in later life. J Pediatr 2004; 144:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/34\">",
"      Buskila D, Neumann L, Zmora E, et al. Pain sensitivity in prematurely born adolescents. Arch Pediatr Adolesc Med 2003; 157:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/35\">",
"      Anand KJ, Scalzo FM. Can adverse neonatal experiences alter brain development and subsequent behavior? Biol Neonate 2000; 77:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/36\">",
"      Ruda MA, Ling QD, Hohmann AG, et al. Altered nociceptive neuronal circuits after neonatal peripheral inflammation. Science 2000; 289:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/37\">",
"      Bhutta AT, Rovnaghi C, Simpson PM, et al. Interactions of inflammatory pain and morphine in infant rats: long-term behavioral effects. Physiol Behav 2001; 73:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/38\">",
"      Anand KJ, Coskun V, Thrivikraman KV, et al. Long-term behavioral effects of repetitive pain in neonatal rat pups. Physiol Behav 1999; 66:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/39\">",
"      Anand KJ, Garg S, Rovnaghi CR, et al. Ketamine reduces the cell death following inflammatory pain in newborn rat brain. Pediatr Res 2007; 62:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/40\">",
"      Porter FL, Grunau RE, Anand KJ. Long-term effects of pain in infants. J Dev Behav Pediatr 1999; 20:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/41\">",
"      Maroney DI. Recognizing the potential effect of stress and trauma on premature infants in the NICU: how are outcomes affected? J Perinatol 2003; 23:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/42\">",
"      Slater R, Fabrizi L, Worley A, et al. Premature infants display increased noxious-evoked neuronal activity in the brain compared to healthy age-matched term-born infants. Neuroimage 2010; 52:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/43\">",
"      Walker SM, Franck LS, Fitzgerald M, et al. Long-term impact of neonatal intensive care and surgery on somatosensory perception in children born extremely preterm. Pain 2009; 141:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/44\">",
"      Odding E, Roebroeck ME, Stam HJ. The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil 2006; 28:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/45\">",
"      Maneyapanda SB, Venkatasubramanian A. Relationship between significant perinatal events and migraine severity. Pediatrics 2005; 116:e555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/46\">",
"      Mitchell A, Boss BJ. Adverse effects of pain on the nervous systems of newborns and young children: a review of the literature. J Neurosci Nurs 2002; 34:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/47\">",
"      Hohmeister J, Kroll A, Wollgarten-Hadamek I, et al. Cerebral processing of pain in school-aged children with neonatal nociceptive input: an exploratory fMRI study. Pain 2010; 150:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/48\">",
"      Anand KJ, Hickey PR. Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 1992; 326:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/49\">",
"      Taylor BJ, Robbins JM, Gold JI, et al. Assessing postoperative pain in neonates: a multicenter observational study. Pediatrics 2006; 118:e992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/50\">",
"      Hummel P, van Dijk M. Pain assessment: current status and challenges. Semin Fetal Neonatal Med 2006; 11:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/51\">",
"      Duhn LJ, Medves JM. A systematic integrative review of infant pain assessment tools. Adv Neonatal Care 2004; 4:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/52\">",
"      Grunau RE, Oberlander T, Holsti L, Whitfield MF. Bedside application of the Neonatal Facial Coding System in pain assessment of premature neonates. Pain 1998; 76:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/53\">",
"      Blauer T, Gerstmann D. A simultaneous comparison of three neonatal pain scales during common NICU procedures. Clin J Pain 1998; 14:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/54\">",
"      McNair C, Ballantyne M, Dionne K, et al. Postoperative pain assessment in the neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed 2004; 89:F537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/55\">",
"      Hummel P, Puchalski M, Creech SD, Weiss MG. Clinical reliability and validity of the N-PASS: neonatal pain, agitation and sedation scale with prolonged pain. J Perinatol 2008; 28:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/56\">",
"      Lawrence J, Alcock D, McGrath P, et al. The development of a tool to assess neonatal pain. Neonatal Netw 1993; 12:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/57\">",
"      Johnston CC, Stevens BJ, Franck LS, et al. Factors explaining lack of response to heel stick in preterm newborns. J Obstet Gynecol Neonatal Nurs 1999; 28:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/58\">",
"      Johnston CC, Stevens BJ, Yang F, Horton L. Differential response to pain by very premature neonates. Pain 1995; 61:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/59\">",
"      Stevens B, McGrath P, Gibbins S, et al. Determining behavioural and physiological responses to pain in infants at risk for neurological impairment. Pain 2007; 127:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/60\">",
"      Anand KJ. Pain assessment in preterm neonates. Pediatrics 2007; 119:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/61\">",
"      van Dijk M, Koot HM, Saad HH, et al. Observational visual analog scale in pediatric pain assessment: useful tool or good riddance? Clin J Pain 2002; 18:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/62\">",
"      Bergqvist L, Eriksson M, Kronsberg S, et al. Seeing through the blind! Ability of hospital staff to differentiate morphine from placebo, in neonates at a placebo controlled trial. Acta Paediatr 2007; 96:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/63\">",
"      Stevens BJ, Pillai Riddell R. Looking beyond acute pain in infancy. Pain 2006; 124:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/64\">",
"      Pillai Riddell R, Racine N. Assessing pain in infancy: the caregiver context. Pain Res Manag 2009; 14:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/65\">",
"      Dunbar AE 3rd, Sharek PJ, Mickas NA, et al. Implementation and case-study results of potentially better practices to improve pain management of neonates. Pediatrics 2006; 118 Suppl 2:S87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/66\">",
"      Anand KJ, International Evidence-Based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn. Arch Pediatr Adolesc Med 2001; 155:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/67\">",
"      Debillon T, Zupan V, Ravault N, et al. Development and initial validation of the EDIN scale, a new tool for assessing prolonged pain in preterm infants. Arch Dis Child Fetal Neonatal Ed 2001; 85:F36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/68\">",
"      Hellerud BC, Storm H. Skin conductance and behaviour during sensory stimulation of preterm and term infants. Early Hum Dev 2002; 70:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31863/abstract/69\">",
"      Harrison D, Boyce S, Loughnan P, et al. Skin conductance as a measure of pain and stress in hospitalised infants. Early Hum Dev 2006; 82:603.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5021 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-183.166.191.243-1D72A0B336-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31863=[""].join("\n");
var outline_f31_7_31863=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Frequency of painful procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Effects of inadequately treated pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      SYSTEMATIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ASSESSMENT OF PAIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pain assessment tools",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Limitations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Staff training",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Our approach",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5021\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5021|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/34/16940\" title=\"table 1\">",
"      Neonatal pain assess tools",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35114?source=related_link\">",
"      Prevention and treatment of neonatal pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_7_31864="Evaluation of chronic pelvic pain in women";
var content_f31_7_31864=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of chronic pelvic pain in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31864/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31864/contributors\">",
"     Fred Howard, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31864/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31864/contributors\">",
"     Robert L Barbieri, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31864/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31864/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/7/31864/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic pelvic pain (CPP) refers to pain of at least six months' duration that occurs below the umbilicus and is severe enough to cause functional disability or require treatment. This problem accounts for approximately 10 percent of all ambulatory referrals to a gynecologist and is a common indication for diagnostic and therapeutic surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/1\">",
"     1",
"    </a>",
"    ]. In fact, CPP is considered the principal indication for approximately 20 percent of all hysterectomies performed for benign disease and at least 40 percent of all gynecological laparoscopies performed annually in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women with chronic pelvic pain (CPP) are often disappointed with the quality of their medical consultations. A survey of women with CPP attending a gynecology clinic found that they want their clinician to: (1) provide personalized care; (2) be empathic and take their symptoms seriously; (3) provide an explanation as to the cause of their pain syndrome; and (4) be reassuring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/4\">",
"     4",
"    </a>",
"    ]. A complete history, physical examination, and counseling can take 45 to 90 minutes in women with CPP. Given the intense time commitment required, the provider may need to schedule more than one visit to complete the initial clinical evaluation and counsel the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The six major sources that contribute to pelvic pain should be considered in evaluating women with CPP (",
"    <a class=\"graphic graphic_table graphicRef58699 \" href=\"mobipreview.htm?4/49/4893\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Gastrointestinal",
"     </li>",
"     <li>",
"      Urological",
"     </li>",
"     <li>",
"      Gynecological",
"     </li>",
"     <li>",
"      Psychological",
"     </li>",
"     <li>",
"      Musculoskeletal",
"     </li>",
"     <li>",
"      Neurological",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The individual disorders associated with CPP are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41384?source=see_link\">",
"     \"Causes of chronic pelvic pain in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pelvic pain assessment form",
"    </span>",
"    &nbsp;&mdash;&nbsp;The International Pelvic Pain Society has developed a detailed",
"    <a class=\"external\" href=\"file://pelvicpain.org/pdf/History_and_Physical_Form/IPPS-H&amp;PformR-MSW.pdf\">",
"     history and physical examination form",
"    </a>",
"    for evaluation of women with CPP. This document includes an extensive review of systems for the reproductive, urological, and gastrointestinal systems; screening questionnaires for sexual and physical abuse, and somatization; and pelvic pain quantification and pain mapping (see below). It may be freely reproduced and distributed as long as the copyright notice recognizing the efforts of the International Pelvic Pain Society remains intact.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pain history",
"    </span>",
"    &nbsp;&mdash;&nbsp;A complete history of the patient's pain, as well as a thorough review of systems with emphasis on symptoms of urinary tract disease, bowel disease, reproductive tract disease, musculoskeletal disorders, and psychoneurological disorders is essential. Any history of prior treatments; substance dependence; sexual, physical, or psychological abuse; and domestic violence should also be sought (",
"    <a class=\"graphic graphic_table graphicRef63413 \" href=\"mobipreview.htm?1/2/1068\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The characteristics of the pain should be noted, including first occurrence, location, intensity, quality, duration, temporal pattern, precipitating and alleviating factors, relationship to urination and defecation, and patterns of radiation. An initial record of the patient's pain intensity level, rated on a visual analog or numerical rating system, should be obtained. Repeat assessments of the pain intensity using the same scale can be helpful to monitor response to treatments. A monthly pain calendar in which the patient records episodes of pain, location, severity (",
"    <a class=\"graphic graphic_form graphicRef50711 \" href=\"mobipreview.htm?30/49/31518\">",
"     form 1",
"    </a>",
"    ), and associated factors (eg, menses, mood, use of medication,",
"    <span class=\"nowrap\">",
"     bowel/bladder",
"    </span>",
"    function, coitus and other physical activities) can also be useful for obtaining this information and gauging response to treatment. It is also important to develop an understanding of the effect of CPP on the woman's life: work, school, social activities, relationships, exercise, sleep, and other areas of concern to the patient.",
"   </p>",
"   <p>",
"    This information can help in differential diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pain that is dull and diffuse and whose location is difficult for the patient to determine is often visceral. In contrast, the patient usually can accurately describe the specific location of somatic pain.",
"     </li>",
"     <li>",
"      Cyclic pelvic pain, especially if associated with severe dysmenorrhea, is often due to a hormonally responsive condition, such as endometriosis or adenomyosis. However, a menstrual cycle-related temporal pattern can be misleading, as several disorders generally considered nonhormonally responsive may worsen before and at menses; notable examples are irritable bowel syndrome and interstitial cystitis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/5-8\">",
"       5-8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/60/39879?source=see_link\">",
"       \"Primary dysmenorrhea in adult women: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Onset of pain during pregnancy or immediately postpartum suggests a musculoskeletal etiology, sometimes referred to as \"peripartum pelvic pain syndrome\" [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/9\">",
"       9",
"      </a>",
"      ]. Risk factors for the development of pelvic girdle pain during pregnancy include a history of prior low back pain, multiparity, and higher weight [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/10\">",
"       10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/1/2074?source=see_link\">",
"       \"Musculoskeletal changes and pain during pregnancy and postpartum\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pain that first develops prior to menarche is unlikely to have a gynecologic etiology.",
"     </li>",
"     <li>",
"      Dysmenorrhea is almost always the initial pain symptom in a patient with endometriosis associated pelvic pain.",
"     </li>",
"     <li>",
"      Referred pain is aching and perceived to be near the surface of the body.",
"     </li>",
"     <li>",
"      Pain associated with nerve entrapment is characteristically described as hot or burning, or as electric shock-like pain. Paresthesia is common with nerve entrapment, as well.",
"     </li>",
"     <li>",
"      Pain that is aggravated by the urge or need to void usually suggests interstitial cystitis, and is less commonly associated with endometriosis or irritable bowel syndrome.",
"     </li>",
"     <li>",
"      Symptoms that occur in relation to abdominal pain may give important information. Weight loss may occur in association with malignancy, nausea and vomiting with bowel obstruction, and change in bowel habits with a colonic lesion.",
"     </li>",
"     <li>",
"      Women with a history of pain due to recurrent urinary tract or yeast infections should be asked about prior culture results; negative cultures or diagnoses that are not culture proven make the diagnosis of recurrent infection suspect.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pain map",
"    </span>",
"    &nbsp;&mdash;&nbsp;Asking the patient to complete a pain map can be helpful for localizing pain (",
"    <a class=\"graphic graphic_figure graphicRef80741 \" href=\"mobipreview.htm?9/23/9586\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/11\">",
"     11",
"    </a>",
"    ]. Pain maps may show that the patient also has pain outside of the pelvis, such as headaches or low back pain or vulvodynia, or may reveal a dermatomal distribution or along a myotome, suggesting a nonvisceral source.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination can be painful in these patients, thus it is important to proceed gently and with patience. The examination of the abdomen should focus upon identifying areas of localized or generalized tenderness, surgical scars, hernias, and the presence of masses. The pelvic examination should include a careful evaluation of the shape, size, and mobility of the pelvic organs, as well as any areas of tenderness (",
"    <a class=\"graphic graphic_table graphicRef75811 \" href=\"mobipreview.htm?6/62/7147\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The goal is to identify tender areas, correlate these areas with the patient's pain map, and determine whether the pain produced on examination represents her CPP.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The components of the general gynecologic examination and examination of the abdomen are described elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42681?source=see_link\">",
"       \"The gynecologic history and pelvic examination\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/24/40323?source=see_link\">",
"       \"History and physical examination in adults with abdominal pain\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Examination of abdominal and pelvic muscles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/12\">",
"       12",
"      </a>",
"      ] can best be accomplished using a single digit, one-handed examination. Using the flat tip of the finger, pressure is applied to the muscle to assess for local tenderness, increased tone, referred pain, or neural symptoms.",
"     </li>",
"     <li>",
"      The pelvic muscles should be examined for tone and tenderness both at rest and during active contraction. Normally, palpation of these muscles should be pain-free, both in the relaxed and contracted state. The levator ani muscles can be contracted by asking the patient to tighten her muscles as though she were trying to stop the flow of urine. The obturator internus is contracted by asking the patient to abduct and internally rotate the ipsilateral leg against light pressure.",
"     </li>",
"     <li>",
"      \"Carnett's\" sign refers to increased local tenderness during muscle tensing. While supine, the patient is asked to perform a straight-leg-raising maneuver (raising both legs off the table at the same time) while the examining finger is on the painful abdominal site (raising only the head while in the supine position can serve the same purpose [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/13\">",
"       13",
"      </a>",
"      ]). This maneuver tightens the rectus abdominis muscles, increasing pain if there is myofascial pain (eg, trigger points, entrapped nerve, hernia, myositis), while true visceral sources of pain are associated with less tenderness when abdominal muscles are tensed. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/19/31030?source=see_link\">",
"       \"Chronic abdominal wall pain\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Orthopedic and postural abnormalities, such as exaggeration of the lumbar lordotic curve and anterior pelvic tilt, should also be noted. Does the patient slouch, is there scoliosis, are the iliac crests at the same height, is one leg shorter than the other (distance from iliac crest to lateral malleolus is not the same for each leg), is there tenderness of any bones or joints? Musculoskeletal dysfunction resulting from chronic assumption of a posture that enhances the lordotic curve in the lumbar and lower thoracic spine and exaggerates the anterior tilt of the pelvis can create hypertonicity and imbalanced pelvic muscles [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/14\">",
"       14",
"      </a>",
"      ]. Inflammation of one or more pelvic joints is another potential source of pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PSYCHOLOGICAL ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A tool for assessing psychological status is provided in the International Pelvic Pain Society's patient evaluation form (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Pelvic pain assessment form'",
"    </a>",
"    above). Other assessment tools are also available. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11481?source=see_link&amp;anchor=H22#H22\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Screening for depression'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27352?source=see_link\">",
"     \"Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .) and (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Some simple screening questions for depression and",
"    <span class=\"nowrap\">",
"     physical/sexual",
"    </span>",
"    abuse include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/15\">",
"     15",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      During the past month, have you felt down, depressed or hopeless?",
"     </li>",
"     <li>",
"      During the past month, have you felt little interest or pleasure in doing things?",
"     </li>",
"     <li>",
"      Have you ever been touched against your will?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies suggest that catastrophizing may be an important psychological characteristic of patients with chronic pain and should be included in the assessment of psychological status and addressed in treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     FINDINGS SUGGESTIVE OF SPECIFIC DISORDERS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Abnormalities of the uterosacral ligament, cervical displacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 40 percent of women with CPP due to endometriosis have physical findings on pelvic examination that suggest the underlying disorder. Three physical findings characteristic of endometriosis are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Uterosacral ligament abnormalities (eg, nodularity or thickening, focal tenderness).",
"     </li>",
"     <li>",
"      Lateral displacement of the cervix caused by asymmetric endometriotic involvement of one uterosacral ligament causing it to shorten (",
"      <a class=\"graphic graphic_figure graphicRef59765 \" href=\"mobipreview.htm?10/47/10997\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Cervical stenosis. A stenotic cervix increases retrograde menstruation, which increases the risk of developing endometriosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Adnexal enlargement may be palpable if an endometrioma is present. Nongynecologic physical findings that are observed more frequently among women with endometriosis are red hair color, scoliosis, and dysplastic nevi [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/11,19,20\">",
"     11,19,20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Enlarged or irregular uterus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with adenomyosis can have a slightly enlarged, globular, tender uterus on physical examination. The diagnosis of uterine myomas is usually based upon the finding of an enlarged, mobile uterus with an irregular contour. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27191?source=see_link\">",
"     \"Uterine adenomyosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6426?source=see_link\">",
"     \"Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Uterine, adnexal, or cervical motion tenderness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine tenderness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cervical motion tenderness are the most common findings on physical examination in women with chronic endometritis related to PID, although many affected women have a completely normal examination. Other symptoms of infection include abnormal uterine bleeding: intermenstrual bleeding; spotting; postcoital bleeding; menorrhagia; or amenorrhea in addition to vague, crampy lower abdominal pain.",
"   </p>",
"   <p>",
"    Adhesions resulting from a surgical procedure can cause pain with movement of viscera. The presence of adhesions should be considered in women with a history of PID, endometriosis, prior pelvic surgery, postoperative history of small bowel obstruction, or impaired fertility.",
"   </p>",
"   <p>",
"    Pelvic congestion syndrome is a controversial entity. Although nonspecific, the major finding on physical examination is marked ovarian tenderness upon gentle compression. There may also be tenderness of the uterus, with cervical motion, and upon deep palpation of the ovary abdominally. The diagnosis is strengthened if the history confirms the shifting location of pain, deep dyspareunia, post-coital pain, and exacerbation of pain after prolonged standing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30681?source=see_link\">",
"     \"Vulvovaginal varicosities and pelvic congestion syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Burning, paresthesias, dysesthesias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pain due to neuropathy characteristically has burning, shock-like, paresthesia, and dysesthesia qualities. Mononeuropathies involving nerves with origins from T10 to L4 may present as CPP. In particular, entrapment of the ilioinguinal nerve after a transverse lower abdominal surgical incision may cause pelvic pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Additionally, pudendal neuralgia may present as pelvic and vulvar pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/39/21113?source=see_link&amp;anchor=H174061632#H174061632\">",
"     \"Abdominal surgical incisions: Prevention and treatment of complications\", section on 'Nerve injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Adnexal mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;An adnexal mass suggests an ovarian neoplasm. Tenderness on palpation of the adnexa implies as inflammatory process, while ascites suggests malignancy. An adnexal mass in the setting of abnormalities of the uterosacral ligament or cervical displacement suggests an endometrioma. A mass at the sidewall after oophorectomy or hysterectomy suggests ovarian remnant or residual ovary syndrome, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diffuse tenderness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Variable tenderness of the abdominal wall, hip girdle, soft tissues of the buttocks, pelvic floor, bladder base, and urethra is almost universally present in women with interstitial",
"    <span class=\"nowrap\">",
"     cystitis/painful",
"    </span>",
"    bladder syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Suburethral or suprapubic pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility of a urethral diverticulum should be considered if there is a suburethral mass, fullness, or tenderness. Suprapubic pain could be related to chronic urinary tract infection, interstitial",
"    <span class=\"nowrap\">",
"     cystitis/painful",
"    </span>",
"    bladder syndrome, or osteitis pubis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5514?source=see_link\">",
"     \"Recurrent urinary tract infection in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26873?source=see_link\">",
"     \"Urethral diverticulum in women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"    </a>",
"    and",
"    <span class=\"nowrap\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/57/20373?source=see_link\">",
"      \"Sports-related groin pain or 'sports hernia'\"",
"     </a>",
"     .)",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Tenderness and contraction of pelvic muscles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Piriformis/levator",
"    ani muscle syndrome is suggested by pain upon single digit, one-handed intravaginal examination of these muscles. The muscles tend to be tightly contracted on vaginal examination and may fasciculate. The anal wink reflex (gently stroking the skin immediately surrounding the anus results in a reflexive contraction of the external anal sphincter) may be absent because the pelvic floor muscles are already contracted. The absence of this reflex could also be due to nerve damage and interruption of the spinal arc.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Abdominal pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abdominal pain can be caused by myriad illnesses including, acute intermittent porphyria, diverticular disease, abdominal malignancies, irritable bowel syndrome, lactose intolerance, and helminthic, and other tropical infectious diseases. Specific considerations pertaining to examination of patients with abdominal pain are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/36/19018?source=see_link\">",
"     \"Diagnostic approach to abdominal pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=see_link\">",
"     \"Differential diagnosis of abdominal pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/24/40323?source=see_link\">",
"     \"History and physical examination in adults with abdominal pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/19/31030?source=see_link\">",
"     \"Chronic abdominal wall pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Vulvar and vestibular pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;In vulvodynia, vulvar pain is usually described as burning pain, which may be generalized or localized, and provoked, unprovoked (spontaneous), or mixed (provoked and unprovoked). Vestibulodynia is characterized by severe pain upon vestibular touch or attempted vaginal entry or tenderness to pressure localized within the vulvar vestibule. These disorders may be mistaken for CPP if examination of the vulva is not performed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/6/8295?source=see_link\">",
"     \"Clinical manifestations and diagnosis of generalized vulvodynia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/46/37609?source=see_link\">",
"     \"Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     ADDITIONAL DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history, physical examination, and psychological assessment are the most important components of the diagnostic evaluation (see above). They are complemented by findings from laboratory tests, imaging, and surgical evaluation, when indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Laboratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing is of limited value in evaluating women with CPP. Based upon the clinical findings, baseline tests may be obtained to screen for a chronic infectious or inflammatory process, and to exclude pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete blood count with differential and erythrocyte sedimentation rate",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"     <li>",
"      Testing for chlamydia and gonorrhea infection",
"     </li>",
"     <li>",
"      Pregnancy test",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Further laboratory testing is based on the clinical impression that emerges after a complete history and physical examination, as well as laboratory and imaging studies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/14/10474?source=see_link&amp;anchor=H11#H11\">",
"     \"Screening for ovarian cancer\", section on 'CA 125'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pelvic ultrasound is highly sensitive for identifying pelvic",
"    <span class=\"nowrap\">",
"     masses/cysts",
"    </span>",
"    and determining the origin of the mass (ovary, uterus, fallopian tube). It is less reliable for distinguishing between benign and malignant neoplasms and diagnosing adenomyosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/40/34440?source=see_link\">",
"     \"Sonographic differentiation of benign versus malignant adnexal masses\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Sonography is particularly useful for detecting small pelvic masses (less than 4 cm in diameter), which often cannot be palpated on bimanual examination. It is also very useful for detecting hydrosalpinges, which point to pelvic inflammatory disease as the cause of CPP.",
"   </p>",
"   <p>",
"    Magnetic resonance imaging is obtained in some cases to better define an abnormality suspected by sonography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/26\">",
"     26",
"    </a>",
"    ] and for diagnosis of adenomyosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/1/24601?source=see_link\">",
"     \"Approach to the patient with an adnexal mass\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19352?source=see_link\">",
"     \"Differential diagnosis of the adnexal mass\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Laparoscopic surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately one-third of outpatient laparoscopic surgical procedures in women are performed because of",
"    <span class=\"nowrap\">",
"     abdominal/pelvic",
"    </span>",
"    pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/27\">",
"     27",
"    </a>",
"    ]. In large series, the type and frequency of laparoscopic findings in women with CPP were: no visible pathology (35 percent), endometriosis (33 percent), adhesions (24 percent), chronic PID (5 percent), ovarian cysts (3 percent), with occasional other diagnoses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of laparoscopy in the evaluation of women with CPP is uncertain. The absence of visible pathology does not exclude a physical basis for the patient's pain, but does exclude several common disorders which can be visualized at surgery (endometriosis, adnexal mass, adhesions, some uterine abnormalities, PID) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/29\">",
"     29",
"    </a>",
"    ]. Nevertheless, the use of laparoscopy in women with CPP should be individualized since histologic diagnosis of endometriosis is not mandatory before medical therapy, adhesiolysis is not necessarily effective for relief of CPP, and adnexal masses and uterine abnormalities can be diagnosed noninvasively by ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If we think CPP is related to endometriosis, we initiate treatment with nonsteroidal antiinflammatory drugs",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    combined estrogen-progestin contraceptives (cyclic or continuous). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28969?source=see_link\">",
"     \"Treatment of chronic pelvic pain in women\"",
"    </a>",
"    .) After a two- to three-month course of empiric medical treatment, we offer laparoscopy to women who have not achieved relief of symptoms and have no strong contraindications to laparoscopic surgery. At the same time, we offer the woman a course of empiric therapy with a GnRH-analogue. CPP will resolve in approximately 50 percent of women who undertake this therapy, so laparoscopy can be avoided [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some women prefer to have the diagnosis of endometriosis confirmed surgically and then discuss all of their treatment options, rather than undergo empiric medical therapy, even if the therapy adequately controls their symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/31\">",
"     31",
"    </a>",
"    ]. Disadvantages of surgery include cost, operative complications, and possible under diagnosis since some women with endometriosis have subtle or poorly visualized endometriotic lesions. Side effects and outcome of medical therapy are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=see_link\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/29/14810?source=see_link\">",
"     \"Overview of the treatment of endometriosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Positive findings at laparoscopy are treated as appropriate for the diagnosis (see individual topic reviews). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28969?source=see_link\">",
"     \"Treatment of chronic pelvic pain in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The management of women with no abnormal findings on physical examination or at laparoscopy is challenging. The accuracy of laparoscopic diagnosis of endometriosis depends upon the location and type of the lesion, the experience of the operator, and whether disease is mild or extensive. A negative laparoscopy by a highly experienced clinician is very reliable for excluding endometriosis, although occult microscopic implants may be present submesothelially in normal appearing peritoneum. For these reasons, a trial of GnRH-analogue therapy is reasonable if the clinical suspicion of endometriosis remains high after a negative laparoscopy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=see_link&amp;anchor=H15#H15\">",
"     \"Pathogenesis, clinical features, and diagnosis of endometriosis\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pelvic congestion is a gynecologic cause of CPP that cannot be visualized on imaging or laparoscopy (varicosities alone are not diagnostic). If pelvic congestion is suspected based on characteristic symptoms (shifting location of pain, deep dyspareunia, post-coital pain, and exacerbation of pain after prolonged standing) and physical findings (ovarian tenderness), pelvic venography should be done to establish the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/44/30408?source=see_link&amp;anchor=H6#H6\">",
"     \"Interventional radiology in management of gynecological disorders\", section on 'Pelvic congestion syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with normal laparoscopic findings should be thoroughly evaluated for nongynecologic causes of CPP (",
"    <a class=\"graphic graphic_table graphicRef58699 \" href=\"mobipreview.htm?4/49/4893\">",
"     table 1",
"    </a>",
"    ). In particular, it is important that evaluation for irritable bowel syndrome, interstitial cystitis, and myofascial pain syndrome be thorough and complete. In many cases, referral to a multidisciplinary pain practice is helpful since the diagnostic and therapeutic approach to CPP varies by the specialty of the treating physician. Psychiatrists often focus on somatization, a history of sexual or physical abuse, and depression. Gastroenterologists evaluate for irritable bowel syndrome. Urologists look for painful bladder syndrome and urethral disorders. Gynecologists concentrate on endometriosis, adenomyosis, and chronic PID as likely causes of the CPP. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41384?source=see_link\">",
"     \"Causes of chronic pelvic pain in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Laparoscopic pain mapping",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conscious laparoscopic pain mapping refers to laparoscopy performed under local anesthesia in which the tissues are probed and pulled with surgical instruments while the patient is asked about the severity and nature of any pain she perceives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/32\">",
"     32",
"    </a>",
"    ]. An etiology may be suggested if the pain induced by iatrogenic manipulation replicates the patient's chronic pain. Ideally, this information would allow a targeted approach to subsequent medical and surgical therapy. The role of conscious laparoscopic pain mapping is unclear, as there are no data from controlled studies showing improvement in outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31864/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/23/42353?source=see_link\">",
"       \"Patient information: Chronic pelvic pain in women (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/55/32627?source=see_link\">",
"       \"Patient information: Chronic pelvic pain in women (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Gastrointestinal, urological, gynecological, psychological, and musculoskeletal sources should be considered in evaluating women with chronic pelvic pain (CPP) (",
"      <a class=\"graphic graphic_table graphicRef58699 \" href=\"mobipreview.htm?4/49/4893\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Use of the International Pelvic Pain Society's form facilitates obtaining the history and performing the physical examination. Asking the patient to complete a pain map can also be helpful for localizing pain (",
"      <a class=\"graphic graphic_figure graphicRef80741 \" href=\"mobipreview.htm?9/23/9586\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'History'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goal of the evaluation is to identify tender areas, correlate these areas with the patient's pain map, and determine whether the pain produced on examination represents her CPP. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory testing is of limited value in evaluating women with CPP. A complete blood count with differential and erythrocyte sedimentation rate, urinalysis, testing for chlamydia and gonorrhea infection, and a pregnancy test may be useful to screen for a chronic infectious or inflammatory process, and to exclude pregnancy. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Laboratory'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pelvic ultrasound is highly sensitive for identifying pelvic masses and determining the origin of the mass (ovary, uterus, fallopian tube). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The use of laparoscopy in women with CPP should be individualized. If we think CPP is related to endometriosis, we suggest empiric treatment with nonsteroidal antiinflammatory drugs",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      combined estrogen-progestin contraceptives (cyclic or continuous) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). After a two- to three-month course of empiric medical treatment, we offer laparoscopy to women who have not achieved relief of symptoms and have no strong contraindications to laparoscopic surgery. At the same time, we offer the woman a course of empiric therapy with a GnRH-analogue. CPP will resolve in approximately 50 percent of women who undertake this therapy, so laparoscopy can be avoided. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Laparoscopic surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/1\">",
"      Reiter RC. A profile of women with chronic pelvic pain. Clin Obstet Gynecol 1990; 33:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/2\">",
"      Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 2002; 99:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/3\">",
"      Howard FM. The role of laparoscopy in chronic pelvic pain: promise and pitfalls. Obstet Gynecol Surv 1993; 48:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/4\">",
"      Price J, Farmer G, Harris J, et al. Attitudes of women with chronic pelvic pain to the gynaecological consultation: a qualitative study. BJOG 2006; 113:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/5\">",
"      Walker EA, Gelfand AN, Gelfand MD, et al. Chronic pelvic pain and gynecological symptoms in women with irritable bowel syndrome. J Psychosom Obstet Gynaecol 1996; 17:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/6\">",
"      Mathias JR, Clench MH, Reeves-Darby VG, et al. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci 1994; 39:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/7\">",
"      Parsons CL, Dell J, Stanford EJ, et al. The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol 2002; 187:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/8\">",
"      Lentz GM, Bavendam T, Stenchever MA, et al. Hormonal manipulation in women with chronic, cyclic irritable bladder symptoms and pelvic pain. Am J Obstet Gynecol 2002; 186:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/9\">",
"      R&ouml;st CC, Jacqueline J, Kaiser A, et al. Prognosis of women with pelvic pain during pregnancy: a long-term follow-up study. Acta Obstet Gynecol Scand 2006; 85:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/10\">",
"      Albert HB, Godskesen M, Korsholm L, Westergaard JG. Risk factors in developing pregnancy-related pelvic girdle pain. Acta Obstet Gynecol Scand 2006; 85:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/11\">",
"      Hornstein MD, Thomas PP, Sober AJ, et al. Association between endometriosis, dysplastic naevi and history of melanoma in women of reproductive age. Hum Reprod 1997; 12:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/12\">",
"      Tu FF, Holt J, Gonzales J, Fitzgerald CM. Physical therapy evaluation of patients with chronic pelvic pain: a controlled study. Am J Obstet Gynecol 2008; 198:272.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/13\">",
"      Sharma JB, Mohanraj P, Jain SK, Roy KK. Increased complication rates in vaginal hysterectomy in genital tuberculosis. Arch Gynecol Obstet 2011; 283:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/14\">",
"      Baker PK. Musculoskeletal origins of chronic pelvic pain. Diagnosis and treatment. Obstet Gynecol Clin North Am 1993; 20:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/15\">",
"      Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/16\">",
"      Quartana PJ, Campbell CM, Edwards RR. Pain catastrophizing: a critical review. Expert Rev Neurother 2009; 9:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/17\">",
"      Propst AM, Storti K, Barbieri RL. Lateral cervical displacement is associated with endometriosis. Fertil Steril 1998; 70:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/18\">",
"      Barbieri RL. Stenosis of the external cervical os: an association with endometriosis in women with chronic pelvic pain. Fertil Steril 1998; 70:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/19\">",
"      Woodworth SH, Singh M, Yussman MA, et al. A prospective study on the association between red hair color and endometriosis in infertile patients. Fertil Steril 1995; 64:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/20\">",
"      Cramer DW, Hornstein MD, Ng WG, Barbieri RL. Endometriosis associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT). Mol Hum Reprod 1996; 2:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/21\">",
"      Beard RW, Reginald PW, Wadsworth J. Clinical features of women with chronic lower abdominal pain and pelvic congestion. Br J Obstet Gynaecol 1988; 95:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/22\">",
"      Balasubramanian S, Morley-Forster P. Chronic pelvic pain due to peripheral neuropathy: a case report. J Obstet Gynaecol Can 2006; 28:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/23\">",
"      Loos MJ, Scheltinga MR, Mulders LG, Roumen RM. The Pfannenstiel incision as a source of chronic pain. Obstet Gynecol 2008; 111:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/24\">",
"      Hough DM, Wittenberg KH, Pawlina W, et al. Chronic perineal pain caused by pudendal nerve entrapment: anatomy and CT-guided perineural injection technique. AJR Am J Roentgenol 2003; 181:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/25\">",
"      Gambone JC, Mittman BS, Munro MG, et al. Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process. Fertil Steril 2002; 78:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/26\">",
"      Cody RF Jr, Ascher SM. Diagnostic value of radiological tests in chronic pelvic pain. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/27\">",
"      Tu FF, Beaumont JL. Outpatient laparoscopy for abdominal and pelvic pain in the United States 1994 through 1996. Am J Obstet Gynecol 2006; 194:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/28\">",
"      Howard FM. The role of laparoscopy in the chronic pelvic pain patient. Clin Obstet Gynecol 2003; 46:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/29\">",
"      Howard FM. The role of laparoscopy in the evaluation of chronic pelvic pain: pitfalls with a negative laparoscopy. J Am Assoc Gynecol Laparosc 1996; 4:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/30\">",
"      Swank DJ, Swank-Bordewijk SC, Hop WC, et al. Laparoscopic adhesiolysis in patients with chronic abdominal pain: a blinded randomised controlled multi-centre trial. Lancet 2003; 361:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/31\">",
"      Ballard K, Lowton K, Wright J. What's the delay? A qualitative study of women's experiences of reaching a diagnosis of endometriosis. Fertil Steril 2006; 86:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/32\">",
"      Yunker A, Steege J. Practical guide to laparoscopic pain mapping. J Minim Invasive Gynecol 2010; 17:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/33\">",
"      Howard FM, El-Minawi AM, Sanchez RA. Conscious pain mapping by laparoscopy in women with chronic pelvic pain. Obstet Gynecol 2000; 96:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31864/abstract/34\">",
"      Swanton A, Iyer L, Reginald PW. Diagnosis, treatment and follow up of women undergoing conscious pain mapping for chronic pelvic pain: a prospective cohort study. BJOG 2006; 113:792.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5467 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-1E1E8CC54B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31864=[""].join("\n");
var outline_f31_7_31864=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H25\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pelvic pain assessment form",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pain history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pain map",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PSYCHOLOGICAL ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      FINDINGS SUGGESTIVE OF SPECIFIC DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Abnormalities of the uterosacral ligament, cervical displacement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Enlarged or irregular uterus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Uterine, adnexal, or cervical motion tenderness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Burning, paresthesias, dysesthesias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diffuse tenderness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Suburethral or suprapubic pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Tenderness and contraction of pelvic muscles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Vulvar and vestibular pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      ADDITIONAL DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Laboratory",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Laparoscopic surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Laparoscopic pain mapping",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/5467\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5467|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?9/23/9586\" title=\"figure 1\">",
"      Myofascial pelvic pain map",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/47/10997\" title=\"figure 2\">",
"      Cervical displacement due to endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5467|Form\">",
"      <a href=\"#\" title=\"FORMS\">",
"       FORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_form\" href=\"mobipreview.htm?30/49/31518\" title=\"form 1\">",
"      Monthly pain scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/5467|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/49/4893\" title=\"table 1\">",
"      Causes of CPP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/2/1068\" title=\"table 2\">",
"      Initial hx female chronic pelvic pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?6/62/7147\" title=\"table 3\">",
"      Chronic pelvic pain examination",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/39/21113?source=related_link\">",
"      Abdominal surgical incisions: Prevention and treatment of complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/1/24601?source=related_link\">",
"      Approach to the patient with an adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/26/41384?source=related_link\">",
"      Causes of chronic pelvic pain in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/19/31030?source=related_link\">",
"      Chronic abdominal wall pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/6/8295?source=related_link\">",
"      Clinical manifestations and diagnosis of generalized vulvodynia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/46/37609?source=related_link\">",
"      Clinical manifestations and diagnosis of localized, provoked vulvodynia (formerly vulvar vestibulitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/36/19018?source=related_link\">",
"      Diagnostic approach to abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/30/16874?source=related_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19352?source=related_link\">",
"      Differential diagnosis of the adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/17/6426?source=related_link\">",
"      Epidemiology, clinical manifestations, diagnosis, and natural history of uterine leiomyomas (fibroids)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/24/40323?source=related_link\">",
"      History and physical examination in adults with abdominal pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/44/30408?source=related_link\">",
"      Interventional radiology in management of gynecological disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/1/2074?source=related_link\">",
"      Musculoskeletal changes and pain during pregnancy and postpartum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/29/14810?source=related_link\">",
"      Overview of the treatment of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/48/19210?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of endometriosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?31/55/32627?source=related_link\">",
"      Patient information: Chronic pelvic pain in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/23/42353?source=related_link\">",
"      Patient information: Chronic pelvic pain in women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/45/27352?source=related_link\">",
"      Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/60/39879?source=related_link\">",
"      Primary dysmenorrhea in adult women: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5514?source=related_link\">",
"      Recurrent urinary tract infection in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/14/10474?source=related_link\">",
"      Screening for ovarian cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/40/34440?source=related_link\">",
"      Sonographic differentiation of benign versus malignant adnexal masses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/57/20373?source=related_link\">",
"      Sports-related groin pain or 'sports hernia'",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42681?source=related_link\">",
"      The gynecologic history and pelvic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/18/28969?source=related_link\">",
"      Treatment of chronic pelvic pain in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/15/26873?source=related_link\">",
"      Urethral diverticulum in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/35/27191?source=related_link\">",
"      Uterine adenomyosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/61/30681?source=related_link\">",
"      Vulvovaginal varicosities and pelvic congestion syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_7_31865="Effect of advanced age on fertility and pregnancy in women";
var content_f31_7_31865=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Effect of advanced age on fertility and pregnancy in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31865/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31865/contributors\">",
"     Ruth C Fretts, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31865/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31865/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31865/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31865/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/7/31865/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no universal definition of advanced reproductive age in women, in part because the effects of increasing age occur as a continuum, rather than as a threshold effect. Fertility clearly declines with advancing age, especially after the mid-30s, and women who conceive are at greater risk of pregnancy complications [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. However, studies have generally observed that most women over 45 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/5-10\">",
"     5-10",
"    </a>",
"    ] or over 50 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/1-3,11\">",
"     1-3,11",
"    </a>",
"    ] have good pregnancy outcomes and are able to cope with the physical and emotional stresses of pregnancy and parenting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/11\">",
"     11",
"    </a>",
"    ]. With use of assisted reproductive techniques (ART), births have been reported to several women 66 years of age and one woman age 70. The oldest woman to achieve a naturally conceived pregnancy was 57 years old.",
"   </p>",
"   <p>",
"    The effects of a woman's age on fertility and pregnancy will be reviewed here. Reproductive concerns related to advanced paternal age are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30567?source=see_link\">",
"     \"Effect of advanced paternal age on fertility and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FERTILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advancing age is associated with prolongation in the average time for achieving conception [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/12\">",
"     12",
"    </a>",
"    ]. Fecundability (ie, the probability of achieving a pregnancy in one menstrual cycle) begins to decline significantly in the early 30s (about age 32), with a more rapid decline a few years later (about age 37) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/13\">",
"     13",
"    </a>",
"    ]. Several lines of evidence from both natural and assisted cycles support this finding:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In historical cohorts in whom deliberate fertility control was rare and conception did not generally precede marriage, the rate of involuntary childlessness in women who married at age 20 to 24, 25 to 29, 30 to 34, 35 to 39, and 40 to 44 was 6, 9, 15, 30, and 64 percent, respectively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/14\">",
"       14",
"      </a>",
"      ]. In other similar groups, the average age of last birth ranged from 40.9 to 45.7 years and 87 to 99 percent of women were infertile at age 45 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/15,16\">",
"       15,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A large well-designed study reported the probability of clinical pregnancy following intercourse on the most fertile cycle day in women of average fertility aged 19 to 26 years, 27 to 34 years, and 35 to 39 years was approximately 50, 40, and 30 percent, respectively, if the male partner was the same age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A classic study of women undergoing donor insemination for male factor infertility (azoospermia) found women &ge;35 years of age had lower conception rates and required more cycles to achieve conception [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/18\">",
"       18",
"      </a>",
"      ]. Women who were 26 to 30 years of age had similar conception rates to women 25 years of age or younger, while women 31 to 35 had an intermediate success rate. Conception rates for women under age 31 years, age 31 to 35 years, and over age 35 years were 74, 62, and 54 percent, respectively.",
"     </li>",
"     <li>",
"      Population-based data on outcome of in vitro fertilization using fresh nondonor eggs showed the success rate for women in their late 30s and early 40s was significantly lower than for women under 37 years of age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/19\">",
"       19",
"      </a>",
"      ]. The live birth rates for nulliparous women &lt;35 years of age, age 35 to 37, age 38 to 40, age 41 to 42, and &gt;42 years were 36, 28, 18,10, and 4 percent per cycle, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pathogenesis of subfertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subfertility in older women is primarily related to the poor quality of aging oocytes (chromosomal abnormalities, morphologic abnormalities, functional abnormalities), decreased ovarian reserve (fewer oocytes), and an altered hormonal environment resulting in ovulatory dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. Only about 5 percent of women with diminished ovarian reserve will achieve pregnancy, despite use of ovulation inducing agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to ovarian factors, older women have had more opportunity to acquire medical and surgical conditions, such as endometriosis, pelvic infection, endometrial polyps, and leiomyomas, which can impair fertility through a variety of mechanisms (see individual topic reviews).",
"   </p>",
"   <p>",
"    Lifestyle factors may also play a role. Older women may have lower coital frequency than younger women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/25\">",
"     25",
"    </a>",
"    ], and are more likely to be obese. A general discussion of lifestyle factors relating to fertility in reproductive aged women can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11482?source=see_link\">",
"     \"Optimizing natural fertility in couples planning pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past half century, older women in the United States have accounted for an increasing proportion of total births [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/26\">",
"     26",
"    </a>",
"    ]. In 2010, just over 14 percent of all births in the United States were to women &ge;35 years of age, and 1 in 12 women gave birth to their first child at this age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/27\">",
"     27",
"    </a>",
"    ]. There were 7725 births to women aged 45 to 54 years, and 27 percent of these births were the woman's first child. The mean age at first birth (25.4 years of age) has increased by about four years since 1970 (21.4 years). The mean age of first-time mothers in other developed countries is increasing, as well: Canada (mean age 29.6 years), Sweden (mean age 28.3 years), and the Netherlands (28.7 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The increased occurrence of births at older maternal ages is due to the increased population of women aged 35 to 45, as well as later marriage, second marriage, the availability of better contraceptive options, and wider opportunities for further education and career advancement. Maternal education is one of the strongest predictors of use of contraception, timing of childbearing, and the total number of children a woman will bear. College educated women tend to have low first birth rates when in their 20s, but higher first birth rates in their 30s, thus illustrating the trend of delayed childbearing related to educational achievement and career opportunities. In surveys, women have cited a desire to achieve career, educational, financial, and personal goals, as well as stability in a marital relationship, before planning pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/30\">",
"     30",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    However, older women also have a high prevalence of contraceptive nonuse resulting in unintended pregnancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/31\">",
"     31",
"    </a>",
"    ]. Although women under age 25 have the highest rate of unintended pregnancy, women &ge;35 years have the highest proportion of unintended pregnancies ending in abortion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     EARLY PREGNANCY ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older women are at risk for the same pregnancy complications as younger women, but their risk is higher for some of these problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Spontaneous abortion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older women experience an increased rate of spontaneous abortion (",
"    <a class=\"graphic graphic_figure graphicRef81823 \" href=\"mobipreview.htm?12/48/13070\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/33\">",
"     33",
"    </a>",
"    ]. These losses are both trisomic and euploid and primarily result from a decline in oocyte quality; changes in uterine and hormonal function may also play a role. The vast majority of losses occur between 6 and 14 weeks of gestation.",
"   </p>",
"   <p>",
"    In a large, well-documented series from Scandinavia, the overall rate of spontaneous abortion managed in a hospital was approximately 11 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/34\">",
"     34",
"    </a>",
"    ]. Assuming that only 80 percent of women with abortions were hospitalized, the calculated risk of spontaneous loss in each age group was: &lt;30 years of age (12 percent), 30 to 34 years (15 percent), 35 to 39 years (25 percent), 40 to 44 years (51 percent), and &ge;45 years (93 percent) (",
"    <a class=\"graphic graphic_table graphicRef70032 \" href=\"mobipreview.htm?37/3/37947\">",
"     table 1",
"    </a>",
"    ). The influence of maternal age on the spontaneous abortion rate was independent of parity and history of previous abortion, although these characteristics were also risk factors for pregnancy loss.",
"   </p>",
"   <p>",
"    The First and Second Trimester Evaluation of Risk (FASTER) trial, which was designed to assess Down syndrome risk, also reported pregnancy outcomes for over 36,000 pregnancies according to maternal age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/35\">",
"     35",
"    </a>",
"    ]. Strengths of this series include its large size, complete medical records, and unselected population; however, women were enrolled at 10 to 14 weeks of gestation so abortions in very early pregnancy, the most common time for pregnancy loss, were excluded. Women with fetuses who had large cystic hygromas were also excluded; these women were also at high risk of spontaneous loss. The rates of spontaneous abortion after 10 weeks of gestation for women &lt;35 years, 35 to 39 years, and &ge;40 years were 0.8, 1.5, and 2.2 percent, respectively.",
"   </p>",
"   <p>",
"    The risk of eventual spontaneous abortion in women of advanced age is significant despite demonstration of fetal cardiac activity by transvaginal ultrasound [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. As an example, in one study of over 2000 consecutive IVF pregnancies, the pregnancy loss rate after demonstrated fetal cardiac activity according to maternal age was: &lt;30 years (5 percent), 31 to 34 years (8 percent), 35 to 39 years (13 percent), and &ge;40 years (22 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/37\">",
"     37",
"    </a>",
"    ]. This shows that the increased rate of pregnancy loss was not confined to blighted ova.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ectopic pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ectopic pregnancy is a major source of maternal mortality and morbidity in early pregnancy. Maternal age &ge;35 years is associated with a four- to eight-fold increased risk of ectopic pregnancy compared with younger women (",
"    <a class=\"graphic graphic_table graphicRef70032 \" href=\"mobipreview.htm?37/3/37947\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/34,38\">",
"     34,38",
"    </a>",
"    ]. This high risk of ectopic pregnancy likely reflects an accumulation of risk factors over time, such as multiple sexual partners, pelvic infection, and tubal pathology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/15/21752?source=see_link\">",
"     \"Incidence, risk factors, and pathology of ectopic pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Chromosomal abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Karyotype analysis from spontaneous abortions, pregnancy terminations, genetic amniocenteses, and live born and stillborn infants shows a steady increase in the risk of aneuploidy as a woman ages (",
"    <a class=\"graphic graphic_table graphicRef75423 \" href=\"mobipreview.htm?16/60/17357\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef81354 \" href=\"mobipreview.htm?37/60/38860\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef50590 \" href=\"mobipreview.htm?17/48/18191\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. The biological basis for this observation is that oocytes reach metaphase I during the fetal period (five months postfertilization) and remain aligned on the metaphase plate until the oocyte is stimulated to divide, just prior to ovulation. Age-related errors appear to increase the risk of nondisjunction leading to unequal chromosome products at completion of division. These age-related errors may be related to cumulative oxidative stress, depletion in the number of normal oocytes available for maturation, and shortening of oocyte telomeres [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/41-46\">",
"     41-46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Theoretically, preimplantation selection of chromosomally and morphologically normal embryos could increase the chances of successful implantation and ongoing pregnancy, as well as avoid chromosomally abnormal births. Despite the high number of aneuploid embryos which are excluded from transfer by this procedure, data from randomized trials and controlled studies have shown that preimplantation selection neither improve the implantation rate nor the rate of live birth. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/56/23431?source=see_link\">",
"     \"Preimplantation genetic diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Gene abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are sparse data on the effect of advanced maternal age on single gene disorders and epigenetic events, other than in the setting of assisted reproduction. Epidemiologic studies have reported an association between advanced maternal and paternal age and risk of autism spectrum disorders in offspring [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/47\">",
"     47",
"    </a>",
"    ]. Although not proven as an independent risk factor for autism, parental age should be examined in large, population-based birth cohorts that have carefully examined potential confounders. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=see_link&amp;anchor=H15#H15\">",
"     \"Terminology, epidemiology, and pathogenesis of autism spectrum disorders\", section on 'Parental age'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Congenital malformations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of having a child with a congenital anomaly may increase with increasing maternal age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/35,48,49\">",
"     35,48,49",
"    </a>",
"    ]. Historically, an increase in congenital anomalies with advancing maternal age has been attributed to the recognized increase of aneuploidy with advancing maternal age and the association of aneuploid fetuses with structural anomalies. However, several analyses have suggested that the risk of nonchromosomal anomalies also increases as women age. Cardiac anomalies, in particular, seem to increase with maternal age independent of aneuploidy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The US National Birth Defects Prevention Study (NBDPS) is a population-based case control study that assessed the association between birth defects and maternal age, adjusted for",
"      <span class=\"nowrap\">",
"       race/ethnicity,",
"      </span>",
"      body mass index,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      use, gravidity, education, smoking, and parental age difference [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/50\">",
"       50",
"      </a>",
"      ]. The study included 20,377 case infants and 8169 control infants and excluded infants with recognized or strongly suspected chromosomal abnormalities or single gene disorders. Compared with the reference group of women 25 to 29 years of age, offspring of women &ge;40 years of age were at increased risk of several types of cardiac defects (aOR 2.2-2.9), as well as for esophageal atresia (aOR, 2.9; 95% CI 1.7&ndash;4.9), hypospadias (aOR, 2.0; 95% CI 1.4&ndash;3.0), and craniosynostosis (aOR, 1.6; 95% CI 1.1&ndash;2.4).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the FASTER trial, the rates of major congenital anomalies for offspring of women &lt;35, 35 to 39, and &ge;40 years of age were 1.7, 2.8, and 2.9 percent, respectively (odds ratios for women &ge;35 compared to women &lt;35 ranged from 1.4 to 1.7) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/35\">",
"       35",
"      </a>",
"      ]. Given the large size of this trial, the authors considered an OR &gt;2 to be clinically significant, and none of these mathematically significant ORs reached this level of clinical relevance [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/49\">",
"       49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Lastly, an in depth analysis of all pregnancy outcomes (livebirths, stillbirths, and terminations) within a geographically confined region of Texas revealed the risk for all nonchromosomal congenital anomalies increased with advancing maternal age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/48\">",
"       48",
"      </a>",
"      ]. Fetuses of women 20 to 24 years of age had a congenital malformation rate of 3.5 percent, which was lower than the rate in women 35 to 39 years and &ge;40 years (4.4 and 5.0 percent, respectively). Cardiac anomalies were notably increased, as well as clubfoot and congenital diaphragmatic hernia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Results worldwide have not been consistent with all of these findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. Differences in study design, case definition, and potential confounders may play a role in these discrepancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     LATE PREGNANCY ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some obstetrical complications in older women appear to be related to the aging process alone, while others are largely related to coexisting factors such as multiple gestation, higher parity, and chronic medical conditions, which are less likely to be observed in younger women. Because high quality data are unavailable, it is difficult to compare the pregnancy outcome of low risk older primigravidae with that of low risk younger primigravidae. Results from small series suggest that low risk older primigravidae generally have good pregnancy outcomes, but not equivalent to that of their younger counterparts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/53,54\">",
"     53,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Effects of coexisting medical conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of medical and surgical illnesses, such as cancer; cardiovascular, renal, and autoimmune disease; and obesity increases with advancing age. For this reason, women &ge;35 years of age can expect to experience two- to three-fold higher rates of hospitalization, cesarean delivery, and pregnancy-related complications than their younger counterparts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/35,55-63\">",
"     35,55-63",
"    </a>",
"    ]. Smoking has been associated with increased perinatal morbidity and stillbirth in all age groups, but the risk is particularly high in older smokers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=see_link\">",
"     \"Smoking and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The two most common medical problems complicating pregnancy are hypertension (preexisting and pregnancy related) and diabetes (pregestational and gestational). Both conditions are increased in older women, especially those who are overweight.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertension is the most common medical problem encountered in pregnancy and is particularly prevalent in older women. The odds of being diagnosed with chronic hypertension are two- to four-fold higher in women &ge;35 years of age than in women 30 to 34 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/63\">",
"     63",
"    </a>",
"    ]. The incidence of preeclampsia in the general obstetric population is 3 to 4 percent; this increases to 5 to 10 percent in women over age 40 and is as high as 35 percent in women over age 50 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Maternal and fetal morbidity and mortality related to hypertensive disorders during pregnancy can be reduced with careful monitoring and appropriately timed intervention, but with an increase in preterm birth, small for gestational age infants, and cesarean delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/59,69,70\">",
"     59,69,70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=see_link\">",
"     \"Management of hypertension in pregnant and postpartum women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link\">",
"     \"Preeclampsia: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of diabetes increases with maternal age; the rates of both preexisting diabetes mellitus and gestational diabetes increase three- to six-fold in women 40 years of age or older compared with women aged 20 to 29 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/35,59,67,68\">",
"     35,59,67,68",
"    </a>",
"    ]. The incidence of gestational diabetes in the general obstetric population is 3 percent, rising to 7 to 12 percent in women over age 40, and 20 percent in women over age 50 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/35,67,68\">",
"     35,67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preexisting diabetes is associated with increased risks of congenital anomalies, perinatal mortality, and perinatal morbidity, while the major complication of gestational diabetes is macrosomia and its sequelae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/27/36281?source=see_link\">",
"     \"Pregnancy risks in women with type 1 and type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/31/42487?source=see_link\">",
"     \"Prepregnancy evaluation and management of women with type 1 or type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/62/37866?source=see_link\">",
"     \"Medical management and follow-up of gestational diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Placental problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of placental problems, such as abruptio placenta and placenta previa, is higher among older women. Multiparity accounts for significant proportion of the excess risk in both disorders. In fact, there is no significant correlation between maternal age and abruption when parity and hypertension are taken into account. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29417?source=see_link\">",
"     \"Placental abruption: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, age, as well as parity, appear to be independent risk factors for placenta previa. Nulliparous women &ge;40 years of age have a 10-fold increased risk of placenta previa compared with nulliparous women age 20 to 29 years, although the absolute risk is small (0.25 versus 0.03 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/59\">",
"     59",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35032?source=see_link\">",
"     \"Clinical features, diagnosis, and course of placenta previa\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Perinatal morbidity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advanced maternal age is responsible for a substantial proportion of the increased rate of low birthweight (LBW) and preterm delivery (PTD) observed in the past several years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/1,35,68,72-76\">",
"     1,35,68,72-76",
"    </a>",
"    ]. These risks were illustrated in several population-based studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective population-based Swedish cohort study restricted to healthy nulliparous women (n = 173,715) delivering singletons compared birth outcome in women age 35 to 40 to those 20 to 24 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/73\">",
"       73",
"      </a>",
"      ]. Demographic characteristics, smoking, history of infertility, and other medical conditions were taken into account when calculating risk. After adjusting for these factors, older age was associated with a significantly higher risk of LBW and PTD: very LBW (OR = 1.9); moderate LBW (OR = 1.7); very preterm birth (OR = 1.7); moderately preterm birth (OR = 1.2); and small for gestational age infant (OR = 1.7).",
"      <br/>",
"      <br/>",
"      A subsequent prospective population-based study from Sweden evaluated outcome in women at more advanced ages and confirmed the increased risk of PTD in older women, after adjustment for confounders such as multiple gestation, smoking, parity, and maternal medical disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/74\">",
"       74",
"      </a>",
"      ]. This series included over 32,000 women &ge;40 years of age. The rates of PTD &lt;32 weeks for women 20 to 29, 40 to 44, and &ge;45 years of age were 1.01, 1.80, and 2.24 percent, respectively.",
"     </li>",
"     <li>",
"      A population-based Canadian series compared birthweight and PTD rates between women aged &ge;35 and those under age 35 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/72\">",
"       72",
"      </a>",
"      ]. Among older mothers, birthweight was slightly, but significantly, lower in every group (&lt;2500 g, &lt;1500 g, &lt;1250 g, &lt;1000 g) (OR 1.1 to 1.6), as was the rate of PTD (&lt;37, &lt;35, &lt;32, and &lt;30 weeks of gestation) (OR 1.1 to 1.3).",
"     </li>",
"     <li>",
"      A population-based study from the United States reported adjusted odds ratios for delivering a LBW white infant increased progressively with each five-year increase in maternal age, reaching 2.3 (95% CI 1.6-3.4) in women &ge;40 years versus those aged 20 to 24 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/75\">",
"       75",
"      </a>",
"      ]. The maternal age effect on both very LBW and PTD was similar (OR 1.8 for the oldest compared with the youngest group).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although older mothers have more PTDs, their preterm neonates are not at increased risk of morbidity compared to preterm neonates of younger women. A population based cohort study of over 12,000 neonates &lt;33 weeks of gestation admitted to Canadian NICUs observed a trend of higher rates of neonatal survival without morbidity with increasing maternal age (adjusted OR 1.047, 95% CI 1.001-1.095) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Perinatal mortality",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26050205\">",
"    <span class=\"h3\">",
"     Fetal death",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large studies worldwide consistently report that older women (&ge;35 years of age) are at significantly increased risk of stillbirth compared with younger women. A systematic review and meta-analysis of these studies calculated that maternal age older than 35 years was associated with a 65 percent increase in the odds of stillbirth (effect size 1.65, 95% CI 1.61-1.71) compared with younger women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/78\">",
"     78",
"    </a>",
"    ]. The relative risk of stillbirth increased with increasing maternal age (ie, higher at age 40 than at age 35). The increased risk of stillbirth is most notable after about 37 weeks of gestation (",
"    <a class=\"graphic graphic_figure graphicRef75607 \" href=\"mobipreview.htm?3/7/3186\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The excess perinatal mortality experienced by older women is largely due to non-anomalous fetal deaths, which are often unexplained, even after controlling for risk factors such as hypertension, diabetes, antepartum bleeding, smoking, and multiple gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/1,74,79,81-88\">",
"     1,74,79,81-88",
"    </a>",
"    ]. Nevertheless, the absolute risk of stillbirth in developed countries is small, even at very advanced maternal ages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective population-based study from Sweden reported the absolute risk of an intrauterine fetal death &ge;28 weeks of gestation or death of the live-born child within the first 28 days of life was 1.1 percent in women aged &ge;40 years (343",
"      <span class=\"nowrap\">",
"       deaths/31,662",
"      </span>",
"      deliveries) and 1.7 percent in women &ge;45 years (20",
"      <span class=\"nowrap\">",
"       deaths/1205",
"      </span>",
"      deliveries) after adjusting for confounders such as parity, congenital malformations, smoking, and maternal disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/74\">",
"       74",
"      </a>",
"      ]. The absolute risk of fetal or neonatal death in offspring of women 20 to 29 years of age was 0.6 percent (5246",
"      <span class=\"nowrap\">",
"       deaths/876,361",
"      </span>",
"      deliveries).",
"     </li>",
"     <li>",
"      An analysis of over five million non-anomalous singleton gestations in the United States found the risk of stillbirth at 37 to 41 weeks for primiparous women increased significantly with maternal age [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/79\">",
"       79",
"      </a>",
"      ]. The risk of stillbirth for women under age 35, age 35 to 39 years old, and over 40 years old was 3.73, 6.41, and 8.65 per 1000 ongoing pregnancies, respectively. The increased risk of stillbirth with increasing age persisted after accounting for medical disease and",
"      <span class=\"nowrap\">",
"       race/ethnicity.",
"      </span>",
"      The risk increased sharply at 40 weeks of gestation, which suggests that older women are \"postterm\" sooner than younger women.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5049749\">",
"    <span class=\"h3\">",
"     Neonatal death",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast to the increased risk of stillbirth with increasing maternal age, the risk of neonatal death among neonates born preterm is lower than in preterm infants of younger women. In the population based cohort study of neonates &lt;33 weeks of gestation admitted to NICUs discussed above, neonatal mortality progressively decreased with increasing maternal age (adjusted OR 0.922, 95% CI 0.855-0.955) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/77\">",
"     77",
"    </a>",
"    ]. This may have been due to differences in underlying factors, such as higher use of prenatal steroids and cesarean delivery and lower rates of substance abuse, in older women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Multiple gestation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advancing age is associated with an increased prevalence of twin pregnancy, which is related to both a higher risk of naturally-conceived twins and a higher use of ART in older women. Interestingly, in contrast to singletons, the outcome of multiple pregnancies in older women is as good or better than the outcome in younger women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/89\">",
"     89",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cesarean delivery and dysfunctional labor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies consistently show that women &ge;35 years of age are more likely than younger women to be delivered by cesarean (RR 1.4-2.8) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/90\">",
"     90",
"    </a>",
"    ]. The cesarean delivery rate in women over age 40 to 45 was about 50 percent and the rate was almost 80 percent in women age 50 to 63 years, at a time when the rate in the general obstetric population of the United States was about 25 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/8,59,67\">",
"     8,59,67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reasons for the high rate of operative delivery in older women are controversial, but include an increased prevalence of medical complications, induction of labor, and fetal malposition, as well as a lower threshold among both patients and physicians for performing a cesarean delivery. Maternal request for cesarean delivery is becoming more common, particularly among older gravidae [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/91\">",
"     91",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/21/344?source=see_link\">",
"     \"Cesarean delivery on maternal request\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When specific indications for cesarean birth are evaluated, older women appear to have an increased risk of cephalopelvic disproportion resulting in failure of labor to progress normally. The almost linear increase in the relationship between maternal age and uterine dysfunction is a continuous effect throughout the childbearing years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/92-94\">",
"     92-94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Older women who undergo a trial of labor after a previous cesarean delivery appear to be at increased risk of both failed trial of labor and uterine rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/95,96\">",
"     95,96",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/10/5290?source=see_link\">",
"     \"Choosing the route of delivery after cesarean birth\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Maternal mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Older women are at increased risk of maternal death, however, advancing age has only a small effect on the risk of maternal death in developed countries since the risk of dying during childbirth is already very low in these areas. In the United States from 1991 to 1997, the risk of pregnancy-related maternal mortality for women 35 to 39 years of age was more than twice that of women aged 25 to 29 years (21 versus 9 per 100,000 live births); the risk in women over 40 years old was five-fold higher (46 versus 9 per 100,000 live births) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40888?source=see_link&amp;anchor=H25#H25\">",
"     \"Overview of maternal mortality\", section on 'Advancing maternal age'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In developing nations, however, maternal mortality remains a significant problem. Lack of adequate care contributes substantially to these maternal losses, but maternal characteristics such as increasing age and parity are also significant contributors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3401384\">",
"    <span class=\"h1\">",
"     OTHER ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;An observational study of longitudinal cohorts noted that increasing maternal age was associated with improved health and development for children up to 5 years of age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/100\">",
"     100",
"    </a>",
"    ]. Outcomes included frequency of unintentional injuries, immunization rates, language development, and social development. Children of older parents have described several benefits, including the devotion, patience, and attention of their parents, as well as their emotional and financial stability [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31865/abstract/101,102\">",
"     101,102",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, older parents should also be aware of the various issues related to their age on offspring, such as possibly being mistaken as grandparents, the increased possibility of parental death or serious illness while the child is young, the increased possibility that the young adult child will become a caregiver to aging parents, and generational issues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of infertility and pregnancy in older women is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/48/35590?source=see_link\">",
"     \"Management of infertility and pregnancy in women of advanced age\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women should be informed that delaying childbearing until the mid 30s significantly increases the risk of infertility and of developing a chronic medical disease which might complicate pregnancy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Fertility'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Pregnancy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women contemplating pregnancy should be counseled to optimize their health (eg, achieve a normal body mass index and avoid smoking, recreational drugs, and alcohol) and seek preconceptional counseling. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/25/16794?source=see_link\">",
"       \"Preconception evaluation and counseling\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pregnancy complications that occur with increased frequency in older gravidae include: ectopic pregnancy, spontaneous abortion, fetal chromosomal abnormalities, some congenital anomalies, placenta previa, gestational diabetes, preeclampsia, and cesarean delivery. Such complications may, in turn, result in preterm birth. There is also an increased risk of perinatal mortality. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Early pregnancy issues'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Late pregnancy issues'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/1\">",
"      Salihu HM, Shumpert MN, Slay M, et al. Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol 2003; 102:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/2\">",
"      Simchen MJ, Yinon Y, Moran O, et al. Pregnancy outcome after age 50. Obstet Gynecol 2006; 108:1084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/3\">",
"      Sauer MV, Paulson RJ, Lobo RA. Pregnancy in women 50 or more years of age: outcomes of 22 consecutively established pregnancies from oocyte donation. Fertil Steril 1995; 64:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/4\">",
"      Luke B, Brown MB. Contemporary risks of maternal morbidity and adverse outcomes with increasing maternal age and plurality. Fertil Steril 2007; 88:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/5\">",
"      Dildy GA, Jackson GM, Fowers GK, et al. Very advanced maternal age: pregnancy after age 45. Am J Obstet Gynecol 1996; 175:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/6\">",
"      Sauer MV, Paulson RJ, Lobo RA. Oocyte donation to women of advanced reproductive age: pregnancy results and obstetrical outcomes in patients 45 years and older. Hum Reprod 1996; 11:2540.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/7\">",
"      Abu-Heija AT, Jallad MF, Abukteish F. Maternal and perinatal outcome of pregnancies after the age of 45. J Obstet Gynaecol Res 2000; 26:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/8\">",
"      Callaway LK, Lust K, McIntyre HD. Pregnancy outcomes in women of very advanced maternal age. Aust N Z J Obstet Gynaecol 2005; 45:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/9\">",
"      Dulitzki M, Soriano D, Schiff E, et al. Effect of very advanced maternal age on pregnancy outcome and rate of cesarean delivery. Obstet Gynecol 1998; 92:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/10\">",
"      Carolan MC, Davey MA, Biro M, Kealy M. Very advanced maternal age and morbidity in Victoria, Australia: a population based study. BMC Pregnancy Childbirth 2013; 13:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/11\">",
"      Steiner AZ, Paulson RJ. Motherhood after age 50: an evaluation of parenting stress and physical functioning. Fertil Steril 2007; 87:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/12\">",
"      Committee on Gynecologic Practice of American College of Obstetricians and Gynecologists, Practice Committee of American Society for Reproductive Medicine. Age-related fertility decline: a committee opinion. Fertil Steril 2008; 90:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/13\">",
"      Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992; 7:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/14\">",
"      Menken J, Trussell J, Larsen U. Age and infertility. Science 1986; 233:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/15\">",
"      TIETZE C. Reproductive span and rate of reproduction among Hutterite women. Fertil Steril 1957; 8:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/16\">",
"      Laufer N, Simon A, Samueloff A, et al. Successful spontaneous pregnancies in women older than 45 years. Fertil Steril 2004; 81:1328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/17\">",
"      Dunson DB, Colombo B, Baird DD. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 2002; 17:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/18\">",
"      Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 1982; 306:404.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/ART/ARTReports.htm (accessed February 13,2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/20\">",
"      Battaglia DE, Goodwin P, Klein NA, Soules MR. Influence of maternal age on meiotic spindle assembly in oocytes from naturally cycling women. Hum Reprod 1996; 11:2217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/21\">",
"      Angell RR. Aneuploidy in older women. Higher rates of aneuploidy in oocytes from older women. Hum Reprod 1994; 9:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/22\">",
"      van Rooij IA, Bancsi LF, Broekmans FJ, et al. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 2003; 79:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/23\">",
"      Rowe T. Fertility and a woman's age. J Reprod Med 2006; 51:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/24\">",
"      Scott RT, Opsahl MS, Leonardi MR, et al. Life table analysis of pregnancy rates in a general infertility population relative to ovarian reserve and patient age. Hum Reprod 1995; 10:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/25\">",
"      Seidman SN, Rieder RO. A review of sexual behavior in the United States. Am J Psychiatry 1994; 151:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/26\">",
"      Ventura SJ, Hamilton BE. Birth Rates Among Women Aged 15&ndash;44 Years, by Maternal Age Group &mdash;National Vital Statistics System, United States, 1961, 2007, and 2011. MMWR Morb Mortal Wkly Rep 2012; 61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/27\">",
"      Births: Final data for 2010. Natl Vital Stat Rep 2012; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     United Nations Economic Commission for Europe. Trends in Europe and North America: the statistical yearbook of the Economic Commission for Europe 2005. Geneva: The Commission; 2005. Available at www.unece.org/stats/trends2.",
"    </li>",
"    <li>",
"     Reproductive Health Working Group. Alberta reproductive health: pregnancies and births 2006; 2006. Available at www.health.gov.ab.ca/resources/publications/reproductive06.pdf.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/30\">",
"      Cooke A, Mills TA, Lavender T. 'Informed and uninformed decision making'--women's reasoning, experiences and perceptions with regard to advanced maternal age and delayed childbearing: a meta-synthesis. Int J Nurs Stud 2010; 47:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/31\">",
"      Wu J, Meldrum S, Dozier A, et al. Contraceptive nonuse among US women at risk for unplanned pregnancy. Contraception 2008; 78:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/32\">",
"      Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006; 38:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/33\">",
"      Hassold T, Chiu D. Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy. Hum Genet 1985; 70:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/34\">",
"      Nybo Andersen AM, Wohlfahrt J, Christens P, et al. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320:1708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/35\">",
"      Cleary-Goldman J, Malone FD, Vidaver J, et al. Impact of maternal age on obstetric outcome. Obstet Gynecol 2005; 105:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/36\">",
"      Smith KE, Buyalos RP. The profound impact of patient age on pregnancy outcome after early detection of fetal cardiac activity. Fertil Steril 1996; 65:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/37\">",
"      Spandorfer SD, Davis OK, Barmat LI, et al. Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss. Fertil Steril 2004; 81:1265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/38\">",
"      Storeide O, Veholmen M, Eide M, et al. The incidence of ectopic pregnancy in Hordaland County, Norway 1976-1993. Acta Obstet Gynecol Scand 1997; 76:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/39\">",
"      Hook EB. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 1981; 58:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/40\">",
"      Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983; 249:2034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/41\">",
"      Hu X, Roberts JR, Apopa PL, et al. Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice. Mol Cell Biol 2006; 26:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/42\">",
"      Warburton D. The effect of maternal age on the frequency of trisomy: change in meiosis or in utero selection? Prog Clin Biol Res 1989; 311:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/43\">",
"      Freeman SB, Yang Q, Allran K, et al. Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome. Am J Hum Genet 2000; 66:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/44\">",
"      Kline, J, Kinne,y A, Levin, B, Warburton, D. Trisomic pregnancy and earlier age at menopause, Am J Hum Genet 2000; 67:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/45\">",
"      Keefe DL, Franco S, Liu L, et al. Telomere length predicts embryo fragmentation after in vitro fertilization in women--toward a telomere theory of reproductive aging in women. Am J Obstet Gynecol 2005; 192:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/46\">",
"      Liu L, Franco S, Spyropoulos B, et al. Irregular telomeres impair meiotic synapsis and recombination in mice. Proc Natl Acad Sci U S A 2004; 101:6496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/47\">",
"      Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch Pediatr Adolesc Med 2007; 161:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/48\">",
"      Hollier LM, Leveno KJ, Kelly MA, et al. Maternal age and malformations in singleton births. Obstet Gynecol 2000; 96:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/49\">",
"      Reefhuis J, Honein MA. Maternal age and non-chromosomal birth defects, Atlanta--1968-2000: teenager or thirty-something, who is at risk? Birth Defects Res A Clin Mol Teratol 2004; 70:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/50\">",
"      Gill SK, Broussard C, Devine O, et al. Association between maternal age and birth defects of unknown etiology: United States, 1997-2007. Birth Defects Res A Clin Mol Teratol 2012; 94:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/51\">",
"      Loane M, Dolk H, Morris JK, EUROCAT Working Group. Maternal age-specific risk of non-chromosomal anomalies. BJOG 2009; 116:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/52\">",
"      Materna-Kiryluk A, Winiewska K, Badura-Stronka M, et al. Parental age as a risk factor for isolated congenital malformations in a Polish population. Paediatr Perinat Epidemiol 2009; 23:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/53\">",
"      Smit Y, Scherjon SA, Knuist M, Treffers PE. Obstetric outcome of elderly low-risk nulliparae. Int J Gynaecol Obstet 1998; 63:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/54\">",
"      Smit Y, Scherjon SA, Treffers PE. Elderly nulliparae in midwifery care in Amsterdam. Midwifery 1997; 13:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/55\">",
"      Newcomb WW, Rodriguez M, Johnson JW. Reproduction in the older gravida. A literature review. J Reprod Med 1991; 36:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/56\">",
"      Hollander D, Breen JL. Pregnancy in the older gravida: how old is old? Obstet Gynecol Surv 1990; 45:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/57\">",
"      Prysak M, Lorenz RP, Kisly A. Pregnancy outcome in nulliparous women 35 years and older. Obstet Gynecol 1995; 85:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/58\">",
"      Edge V, Laros RK Jr. Pregnancy outcome in nulliparous women aged 35 or older. Am J Obstet Gynecol 1993; 168:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/59\">",
"      Gilbert WM, Nesbitt TS, Danielsen B. Childbearing beyond age 40: pregnancy outcome in 24,032 cases. Obstet Gynecol 1999; 93:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/60\">",
"      Bianco A, Stone J, Lynch L, et al. Pregnancy outcome at age 40 and older. Obstet Gynecol 1996; 87:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/61\">",
"      Seoud MA, Nassar AH, Usta IM, et al. Impact of advanced maternal age on pregnancy outcome. Am J Perinatol 2002; 19:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/62\">",
"      Jolly M, Sebire N, Harris J, et al. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod 2000; 15:2433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/63\">",
"      Luke B, Brown MB. Elevated risks of pregnancy complications and adverse outcomes with increasing maternal age. Hum Reprod 2007; 22:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/64\">",
"      Salihu HM, Shumpert MN, Aliyu MH, et al. Smoking-associated fetal morbidity among older gravidas: a population study. Acta Obstet Gynecol Scand 2005; 84:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/65\">",
"      Salihu HM, Shumpert MN, Aliyu MH, et al. Stillbirths and infant deaths associated with maternal smoking among mothers aged &gt; or =40 years: a population study. Am J Perinatol 2004; 21:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/66\">",
"      Aliyu MH, Salihu HM, Wilson RE, et al. The risk of intrapartum stillbirth among smokers of advanced maternal age. Arch Gynecol Obstet 2008; 278:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/67\">",
"      Paulson RJ, Boostanfar R, Saadat P, et al. Pregnancy in the sixth decade of life: obstetric outcomes in women of advanced reproductive age. JAMA 2002; 288:2320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/68\">",
"      Yogev Y, Melamed N, Bardin R, et al. Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol 2010; 203:558.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/69\">",
"      Barton JR, Bergauer NK, Jacques DI, et al. Does advanced maternal age affect pregnancy outcome in women with mild hypertension remote from term? Am J Obstet Gynecol 1997; 176:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/70\">",
"      Zeitlin JA, Ancel PY, Saurel-Cubizolles MJ, Papiernik E. Are risk factors the same for small for gestational age versus other preterm births? Am J Obstet Gynecol 2001; 185:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/71\">",
"      Casey BM, Lucas MJ, Mcintire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol 1997; 90:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/72\">",
"      Tough SC, Newburn-Cook C, Johnston DW, et al. Delayed childbearing and its impact on population rate changes in lower birth weight, multiple birth, and preterm delivery. Pediatrics 2002; 109:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/73\">",
"      Cnattingius S, Forman MR, Berendes HW, Isotalo L. Delayed childbearing and risk of adverse perinatal outcome. A population-based study. JAMA 1992; 268:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/74\">",
"      Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol 2004; 104:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/75\">",
"      Aldous MB, Edmonson MB. Maternal age at first childbirth and risk of low birth weight and preterm delivery in Washington State. JAMA 1993; 270:2574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/76\">",
"      Delpisheh A, Brabin L, Attia E, Brabin BJ. Pregnancy late in life: a hospital-based study of birth outcomes. J Womens Health (Larchmt) 2008; 17:965.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/77\">",
"      Kanungo J, James A, McMillan D, et al. Advanced maternal age and the outcomes of preterm neonates: a social paradox? Obstet Gynecol 2011; 118:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/78\">",
"      Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet 2011; 377:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/79\">",
"      Reddy UM, Ko CW, Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am J Obstet Gynecol 2006; 195:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/80\">",
"      Haavaldsen C, Sarfraz AA, Samuelsen SO, Eskild A. The impact of maternal age on fetal death: does length of gestation matter? Am J Obstet Gynecol 2010; 203:554.e1.",
"     </a>",
"    </li>",
"    <li>",
"     Fretts, RC, Usher, RH. Fetal death in women in the older reproductive age group. Contemporary Reviews in Obstetrics and Gynecology 1997; 173.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/82\">",
"      Bateman BT, Simpson LL. Higher rate of stillbirth at the extremes of reproductive age: a large nationwide sample of deliveries in the United States. Am J Obstet Gynecol 2006; 194:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/83\">",
"      Fretts RC, Schmittdiel J, McLean FH, et al. Increased maternal age and the risk of fetal death. N Engl J Med 1995; 333:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/84\">",
"      Fretts RC, Usher RH. Causes of fetal death in women of advanced maternal age. Obstet Gynecol 1997; 89:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/85\">",
"      Huang DY, Usher RH, Kramer MS, et al. Determinants of unexplained antepartum fetal deaths. Obstet Gynecol 2000; 95:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/86\">",
"      Fr&oslash;en JF, Arnestad M, Frey K, et al. Risk factors for sudden intrauterine unexplained death: epidemiologic characteristics of singleton cases in Oslo, Norway, 1986-1995. Am J Obstet Gynecol 2001; 184:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/87\">",
"      Canterino JC, Ananth CV, Smulian J, et al. Maternal age and risk of fetal death in singleton gestations: USA, 1995-2000. J Matern Fetal Neonatal Med 2004; 15:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/88\">",
"      Miller DA. Is advanced maternal age an independent risk factor for uteroplacental insufficiency? Am J Obstet Gynecol 2005; 192:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/89\">",
"      Delbaere I, Verstraelen H, Goetgeluk S, et al. Perinatal outcome of twin pregnancies in women of advanced age. Hum Reprod 2008; 23:2145.",
"     </a>",
"    </li>",
"    <li>",
"     Bayrampour, H, Heaman, M. Advanced maternal age and the risk of cesarean birth: A systematic review. Birth 2010; 37:219.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/91\">",
"      Lin HC, Xirasagar S. Maternal age and the likelihood of a maternal request for cesarean delivery: a 5-year population-based study. Am J Obstet Gynecol 2005; 192:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/92\">",
"      Main DM, Main EK, Moore DH 2nd. The relationship between maternal age and uterine dysfunction: a continuous effect throughout reproductive life. Am J Obstet Gynecol 2000; 182:1312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/93\">",
"      Treacy A, Robson M, O'Herlihy C. Dystocia increases with advancing maternal age. Am J Obstet Gynecol 2006; 195:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/94\">",
"      Greenberg MB, Cheng YW, Sullivan M, et al. Does length of labor vary by maternal age? Am J Obstet Gynecol 2007; 197:428.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/95\">",
"      Bujold E, Hammoud AO, Hendler I, et al. Trial of labor in patients with a previous cesarean section: does maternal age influence the outcome? Am J Obstet Gynecol 2004; 190:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/96\">",
"      Shipp TD, Zelop C, Repke JT, et al. The association of maternal age and symptomatic uterine rupture during a trial of labor after prior cesarean delivery. Obstet Gynecol 2002; 99:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/97\">",
"      Callaghan WM, Berg CJ. Pregnancy-related mortality among women aged 35 years and older, United States, 1991-1997. Obstet Gynecol 2003; 102:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/98\">",
"      Chang J, Elam-Evans LD, Berg CJ, et al. Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ 2003; 52:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/99\">",
"      Anderson, FW, Johnson, TR. Maternal Mortality at Y2K. Postgrad Obstet Gynecol 2000; 20:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31865/abstract/100\">",
"      Sutcliffe AG, Barnes J, Blesky J, et al.. The health and development of children born to older mothers in the United Kingdom: observational study using longitudinal cohort data. BMJ Open 2012; 345:e5116.",
"     </a>",
"    </li>",
"    <li>",
"     Morris M. Last-chance children: growing up with older parents, Columbia University Press, New York 1988.",
"    </li>",
"    <li>",
"     Yarrow A. Latecomers: children of parents over 35, Free Press, MacMillan, New York 1991.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 421 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-6ABA7822FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31865=[""].join("\n");
var outline_f31_7_31865=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FERTILITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pathogenesis of subfertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      EARLY PREGNANCY ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Spontaneous abortion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Chromosomal abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Gene abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      LATE PREGNANCY ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Effects of coexisting medical conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Hypertension",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Placental problems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Perinatal morbidity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Perinatal mortality",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26050205\">",
"      - Fetal death",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5049749\">",
"      - Neonatal death",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Multiple gestation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cesarean delivery and dysfunctional labor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Maternal mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3401384\">",
"      OTHER ISSUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/421\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/421|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/48/13070\" title=\"figure 1\">",
"      Miscarriage rates by age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/7/3186\" title=\"figure 2\">",
"      Stillbirth risk by GA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/421|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/3/37947\" title=\"table 1\">",
"      Percent pregnancy loss by maternal age at conception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/60/17357\" title=\"table 2\">",
"      Maternal age-related Down syndrome risk at 3 gestational ages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/60/38860\" title=\"table 3\">",
"      Maternal age aneuploidy risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/48/18191\" title=\"table 4\">",
"      Risk of various aneuplodies by maternal age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/21/344?source=related_link\">",
"      Cesarean delivery on maternal request",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/10/5290?source=related_link\">",
"      Choosing the route of delivery after cesarean birth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/13/35032?source=related_link\">",
"      Clinical features, diagnosis, and course of placenta previa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/54/30567?source=related_link\">",
"      Effect of advanced paternal age on fertility and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/15/21752?source=related_link\">",
"      Incidence, risk factors, and pathology of ectopic pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=related_link\">",
"      Management of hypertension in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/48/35590?source=related_link\">",
"      Management of infertility and pregnancy in women of advanced age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/62/37866?source=related_link\">",
"      Medical management and follow-up of gestational diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/13/11482?source=related_link\">",
"      Optimizing natural fertility in couples planning pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/59/40888?source=related_link\">",
"      Overview of maternal mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/46/29417?source=related_link\">",
"      Placental abruption: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/25/16794?source=related_link\">",
"      Preconception evaluation and counseling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=related_link\">",
"      Preeclampsia: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/27/36281?source=related_link\">",
"      Pregnancy risks in women with type 1 and type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/56/23431?source=related_link\">",
"      Preimplantation genetic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/31/42487?source=related_link\">",
"      Prepregnancy evaluation and management of women with type 1 or type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=related_link\">",
"      Smoking and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/37/4698?source=related_link\">",
"      Terminology, epidemiology, and pathogenesis of autism spectrum disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_7_31866="An overview of endometrial ablation";
var content_f31_7_31866=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   An overview of endometrial ablation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31866/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31866/contributors\">",
"     Howard T Sharp, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31866/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31866/contributors\">",
"     Tommaso Falcone, MD, FRCSC, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/7/31866/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/7/31866/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/7/31866/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with abnormal uterine bleeding have a variety of therapeutic options. Endometrial ablation has become an increasingly popular treatment, since it is minimally invasive and successful ablation avoids chronic use of medications. In a national study in England from 2003 to 2006, 60 percent of all surgical procedures performed for menorrhagia were endometrial ablations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endometrial ablation is the surgical destruction of the uterine lining. This can be accomplished under hysteroscopic visualization, using resectoscopic instruments to ablate or resect the endometrium. It can also be performed with a non-resectoscopic ablation device, which is inserted into the uterine cavity and delivers energy to uniformly destroy the uterine lining. Non-resectoscopic endometrial ablation techniques are more widely practiced than resectoscopic ablation, since they require less specialized training and often have a shorter operative time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/2\">",
"     2",
"    </a>",
"    ]. Endometrial ablation is not appropriate for women with endometrial hyperplasia or cancer, or those who wish to preserve their fertility.",
"   </p>",
"   <p>",
"    This topic review will provide an overview of endometrial ablation. Techniques for non-resectoscopic endometrial ablation and resectoscopic endometrial ablation or resection, as well as other management options for abnormal uterine bleeding, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/393?source=see_link\">",
"     \"Endometrial ablation: Non-resectoscopic techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44708?source=see_link\">",
"     \"Endometrial ablation or resection: Resectoscopic techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=see_link\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Terminology used to describe endometrial ablation varies. In this topic review, the following terms will be used:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endometrial ablation &mdash; Surgical destruction of the endometrium. The endometrium must be destroyed or resected to the level of the basalis (",
"      <a class=\"graphic graphic_figure graphicRef54487 \" href=\"mobipreview.htm?43/27/44465\">",
"       figure 1",
"      </a>",
"      ), which is approximately 4 to 6 mm deep, depending upon the stage of the menstrual cycle. In this topic review, endometrial ablation will refer to either non-resectoscopic ablation or resectoscopic ablation, or resection of the endometrium.",
"     </li>",
"     <li>",
"      Non-resectoscopic endometrial ablation &mdash; Endometrial ablation is performed with a disposable device which is inserted into the uterine cavity and delivers energy to uniformly destroy the uterine lining. Current non-resectoscopic technologies approved for use in the United States by the Food and Drug Association (FDA) are: bipolar radiofrequency (Novasure&reg;); hot liquid filled balloon (ThermaChoice&reg;); cryotherapy (Her Option&reg;); circulating hot water (Hydro ThermAblator&reg;); and microwave (Microwave Endometrial Ablation). These techniques are also referred to as global or second generation ablation.",
"     </li>",
"     <li>",
"      Resectoscopic endometrial ablation &mdash; Endometrial ablation or resection performed under hysteroscopic visualization with resectoscopic electrosurgical instruments (eg, rollerball, wire loop, vaporizing electrode) or with laser. Endometrial resection is often referred to as transcervical resection of the endometrium. Resectoscopic ablation methods are also referred to as standard or first generation ablation. The term hysteroscopic ablation is also sometimes used for these methods; however, this designation would also include the circulating hot water non-resectoscopic technique, since it involves instilling water through a hysteroscope.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary indication for endometrial ablation is treatment of ovulatory menorrhagia in premenopausal women. Ablation in women with anovulatory bleeding or postmenopausal women is discussed below (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Risk factors for endometrial cancer'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Ablation is usually used to treat women with chronic menorrhagia. It may also be used for acute abnormal uterine bleeding in hemodynamically stable women in whom medical therapy is contraindicated or unsuccessful. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/2/11305?source=see_link&amp;anchor=H28#H28\">",
"     \"Managing an episode of severe or prolonged uterine bleeding\", section on 'Endometrial ablation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endometrial ablation is not indicated for women who wish to be amenorrheic for nonmedical reasons; in fact, many women do not develop amenorrhea after ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H41\">",
"     'Improvement in bleeding symptoms'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/47/3832?source=see_link\">",
"     \"Hormonal contraception for suppression of menstruation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial ablation is contraindicated in women with the following conditions or characteristics [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pregnancy",
"     </li>",
"     <li>",
"      Known or suspected endometrial hyperplasia or cancer",
"     </li>",
"     <li>",
"      Desire to preserve fertility",
"     </li>",
"     <li>",
"      Active pelvic infection",
"     </li>",
"     <li>",
"      Intrauterine device in place",
"     </li>",
"     <li>",
"      Previous transmyometrial uterine surgery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Endometrial ablation is also relatively contraindicated in women who are postmenopausal, have congenital uterine anomalies (eg, bicornuate uterus), have a uterine cavity length that is greater than 10 to 12 cm, or have severe myometrial thinning.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Endometrial hyperplasia or cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heavy menstrual bleeding is an indication for endometrial ablation, but may also signify the presence of endometrial hyperplasia or cancer. Therefore, endometrial sampling should be performed in all women prior to undergoing endometrial ablation (see",
"    <a class=\"local\" href=\"#H22\">",
"     'Endometrial sampling'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Endometrial ablation is not a treatment for endometrial hyperplasia or cancer and may interfere with subsequent evaluation of the endometrium (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Risk factors for endometrial cancer'",
"    </a>",
"    below). Thus, endometrial ablation is not appropriate in women with these conditions. This position is consistent with the recommendation of the American College of Obstetricians and Gynecologists (ACOG) that women with endometrial hyperplasia or uterine cancer should not undergo endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Desire to preserve fertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is contraindicated following endometrial ablation since the destruction of the endometrium may result in abnormal implantation or placentation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/5,6\">",
"     5,6",
"    </a>",
"    ] (see",
"    <a class=\"local\" href=\"#H56\">",
"     'Pregnancy after ablation'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Endometrial ablation does not prevent pregnancy. Women must be counseled that contraception will be necessary following the procedure. Some women choose to undergo concomitant ablation and sterilization (see",
"    <a class=\"local\" href=\"#H448471\">",
"     'Sterilization'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Uterine anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial ablation should generally be avoided in women with congenital anomalies of the uterus (eg, septum, unicornuate uterus). There are case reports of non-resectoscopic ablation in women with a bicornuate uterus, but this is not standard practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Some surgeons with advanced hysteroscopic skills may be able to safely and successfully perform ablation in women with these abnormalities using resectoscopic techniques.",
"   </p>",
"   <p>",
"    Acute retro- or anteflexion or retro- or anteversion of the uterus are not contraindications to endometrial ablation. In women with these uterine characteristics, incomplete ablation may result if the fundus cannot be reached with a non-resectoscopic ablation device. Thus, resectoscopic ablation may be preferable in this population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Myometrial thinning following uterine surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial ablation in women with thinning of the myometrium may result in injury to the adjacent viscera (bladder, bowel) if the energy used for ablation passes through the uterine tissue [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/4,9\">",
"     4,9",
"    </a>",
"    ]. There are no data to establish the minimum myometrial thickness required to prevent such complications.",
"   </p>",
"   <p>",
"    Attenuation of the myometrium is usually due to a prior uterine surgery (eg, cesarean delivery, myomectomy). There is no evidence that prior cesarean delivery increases the risk of complications associated with endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/10\">",
"     10",
"    </a>",
"    ]. As an example, one retrospective cohort study found no difference in operative complication or efficacy in women who had one or more cesarean deliveries compared with other women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/11\">",
"     11",
"    </a>",
"    ]. Myometrial thickness was not measured.",
"   </p>",
"   <p>",
"    When microwave ablation was first introduced in Europe, there were reports of thermal injury to adjacent structures in women with no uterine perforation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/12\">",
"     12",
"    </a>",
"    ]. For this reason, instructions for use of the manufacturer of the Microwave Endometrial Ablation system advise a minimum myometrial thickness of 10 mm as documented by ultrasound. While measurement of myometrial thickness is not a requirement for the other four non-resectoscopic ablation devices, surgeons should use clinical judgment to assess the risk of thermal injury when offering non-resectoscopic endometrial ablation to a patient with a history of cesarean delivery or transmural myomectomy. Evaluation of myometrial thickness is discussed below (see",
"    <a class=\"local\" href=\"#H21\">",
"     'Uterine evaluation'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Postmenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest not performing endometrial ablation in postmenopausal women. Endometrial ablation has been described in this population, mostly in women with persistent bleeding while on postmenopausal hormone therapy. Prospective series have reported no cases of endometrial cancer in women who underwent endometrial ablation after menopause; however, these studies included fewer than 50 women and most patients were followed for less than five years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Excluding malignancy is the primary objective in the diagnostic evaluation of women with postmenopausal bleeding. As discussed below, diagnosis of endometrial cancer may be more difficult following endometrial ablation (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Risk factors for endometrial cancer'",
"    </a>",
"    below). Bleeding in postmenopausal women due to benign causes is often managed expectantly or the specific etiology is treated (eg, removal of an endometrial polyp, use of a continuous rather than a cyclic regimen for hormone therapy). Given these other options, it does not appear that the benefit of endometrial ablation outweighs the risk of a missed diagnosis of endometrial cancer in postmenopausal women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/41/2711?source=see_link\">",
"     \"Postmenopausal uterine bleeding\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/34/40486?source=see_link&amp;anchor=H4#H4\">",
"     \"Continuous postmenopausal hormone therapy\", section on 'Induction of amenorrhea'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    United States professional organizations also do not support the use of endometrial ablation in postmenopausal women. The American Society for Reproductive Medicine advised that endometrial ablation is not indicated for postmenopausal women and the American College of Obstetricians and Gynecologists states that it has not been rigorously studied in this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/4,14\">",
"     4,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Special considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women with certain characteristics, endometrial ablation may not be as safe or effective as other therapeutic options. These include women with risk factors for endometrial cancer or with certain uterine characteristics or pathology (eg, submucosal leiomyomas, adenomyosis, large cavity size).",
"   </p>",
"   <p>",
"    Current FDA labeling recommends that endometrial ablation NOT be performed concomitantly with hysteroscopic tubal sterilization (Essure&reg; or Adiana&reg;) due to concerns that uterine synechiae formed following endometrial ablation will interfere with the ability to perform a hysterosalpingogram to confirm tubal occlusion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12665?source=see_link&amp;anchor=H9272913#H9272913\">",
"     \"Hysteroscopic sterilization\", section on 'Endometrial ablation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Risk factors for endometrial cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The safety of endometrial ablation has not been well studied in women who do not currently have endometrial neoplasia, but are at an increased risk of developing endometrial cancer (",
"    <a class=\"graphic graphic_table graphicRef62089 \" href=\"mobipreview.htm?38/30/39403\">",
"     table 1",
"    </a>",
"    ). Ablation itself does not appear to increase the risk of subsequent endometrial cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=see_link&amp;anchor=H2#H2\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of high quality data, the decision to perform endometrial ablation in women with risk factors for endometrial cancer depends mainly upon three factors: the degree to which endometrial ablation may limit future diagnosis of malignancy, the magnitude of the risk of endometrial cancer, and the feasibility of other therapeutic options.",
"   </p>",
"   <p>",
"    Endometrial ablation results in intrauterine adhesions that may obscure the bleeding that is the cardinal symptom of endometrial cancer",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    interfere with endometrial sampling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/16-30\">",
"     16-30",
"    </a>",
"    ]. In addition, histologic evaluation of endometrial samples from women who have undergone ablation may be difficult [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/28-32\">",
"     28-32",
"    </a>",
"    ]. There are no data regarding the sonographic appearance of the endometrium in postmenopausal women following endometrial ablation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=see_link\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many of the reports of endometrial cancer after endometrial ablation have been in women with chronic anovulation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    endometrial hyperplasia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/17,19,33\">",
"     17,19,33",
"    </a>",
"    ]. Women with these conditions are also often obese or have diabetes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hypertension and thus may have contraindications to some medical therapies (eg, steroid hormones, antifibrinolytics) and be at increased risk of complications if they undergo major surgery. We suggest that progestin supplementation be offered to prevent hyperplasia until ovulation is reestablished or menopause occurs in the presence of chronic anovulatory states.",
"   </p>",
"   <p>",
"    Correction of anovulation is the optimal approach to treatment for these women. In women in whom this is not possible, other treatment options (eg, progestins) may be preferable to endometrial ablation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=see_link&amp;anchor=H12#H12\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\", section on 'Women with anovulatory cycles'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are few data regarding endometrial ablation in women taking",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    , and there are no studies with long-term follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. We suggest",
"    <strong>",
"     not",
"    </strong>",
"    performing endometrial ablation in women who are taking tamoxifen. Such women are at an increased risk of endometrial cancer, and ablation may interfere with the later diagnosis of this disorder. In addition, endometrial ablation is not necessary for tamoxifen-induced bleeding, which will resolve after the cessation of tamoxifen therapy.",
"   </p>",
"   <p>",
"    Women with Lynch syndrome (hereditary nonpolyposis colorectal cancer) are at a markedly increased risk of endometrial cancer and are advised to undergo hysterectomy after they have completed childbearing. Thus, abnormal uterine bleeding in this population should not be treated with endometrial ablation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18233?source=see_link\">",
"     \"Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Leiomyomas or polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial ablation in women with intracavitary (submucosal or intramural myomas that protrude into the uterine cavity) fibroids is controversial. Fibroids are a common etiology of abnormal uterine bleeding. Non-resectoscopic ablation is a technically less challenging procedure than hysteroscopic myomectomy, and surgeons may desire to perform ablation for women with an isolated intracavitary fibroid. However, there is a concern that the presence of a lesion protruding into the uterine cavity may interfere with the function of some ablation devices.",
"   </p>",
"   <p>",
"    Endometrial ablation does not treat the fibroid itself; ablation procedures do not remove or shrink fibroids. One study found no histologic effect on leiomyomas following bipolar radiofrequency endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Non-resectoscopic techniques are not explicitly approved by the FDA for use with submucosal fibroids, although this patient population was included in the approval studies for some of the devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Thus, when performing non-resectoscopic ablation in patients with intracavitary fibroids, the surgeon should obtain informed consent regarding off-label use of the device.",
"   </p>",
"   <p>",
"    Comparative data show that non-resectoscopic devices are less effective in women with intracavitary fibroids than in those with a normal uterine cavity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/40-43\">",
"     40-43",
"    </a>",
"    ]. As an example, in a retrospective cohort study of women who underwent Hydro ThermAblator&reg; procedures, women with submucosal fibroids (1 to 4 cm) compared with controls had significantly higher rates of menorrhagia (12 versus 3 percent) and hysterectomy (12 versus 1 percent) at an average of 5.8 years postoperatively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a prospective series of women with fibroids up to 3 cm who underwent bipolar radiofrequency ablation reported that, at one-year follow-up, 95 percent had improvement in uterine bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/44\">",
"     44",
"    </a>",
"    ]. In addition, hot liquid filled balloon ablation was used successfully in 45 women with submucosal fibroids &le;3 cm in a randomized trial comparing balloon versus rollerball ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/4,45\">",
"     4,45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Further study is needed to establish which of the non-resectoscopic devices can be used in women with intracavitary fibroids and appropriate criteria for such use.",
"   </p>",
"   <p>",
"    Resectoscopic endometrial ablation can usually be performed in women with small intracavitary fibroids, or alternatively, a concomitant hysteroscopic myomectomy may be appropriate (see",
"    <a class=\"local\" href=\"#H32\">",
"     'Hysteroscopic myomectomy'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Endometrial polyps are more removed prior to endometrial ablation. However, women with endometrial polyps were included in the FDA approval studies for the Microwave Endometrial Ablation device, Novasure&reg;, and Thermachoice&reg; hot liquid filled balloon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/39,46,47\">",
"     39,46,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/10/7336?source=see_link\">",
"     \"Endometrial polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Cavity size",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women with a large uterus on pelvic examination (&gt;10 weeks size), it is prudent to sound the uterus to assess cavity depth prior to planning an endometrial ablation. Each non-resectoscopic endometrial ablation device can accommodate a different minimum (4 to 6 cm) and maximum (10 to 12 cm) uterine cavity size. The cavity sizes for each device are listed in the table. Ablation may be incomplete in women with a cavity larger than the maximum.",
"   </p>",
"   <p>",
"    Cavity size is less important for resectoscopic ablation, but operative duration, irrigation fluid absorption, and potential blood loss make these methods impractical in women with a uterus larger than 12 weeks size. Successful improvement of uterine bleeding symptoms has been reported following partial ablation with resectoscopic ablation or resection, but not for non-resectoscopic techniques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Adenomyosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adenomyosis (uterine adenomyomatosis) is not a contraindication to endometrial ablation, although women with this condition may have a lower treatment success rate. A retrospective study of 816 women who were followed for five years after endometrial ablation reported that women with a preoperative ultrasound suggestive of adenomyosis had a 1.7-fold increased risk of subsequent hysterectomy or repeat endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Parity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nulliparity is not a contraindication to endometrial ablation. Grand multiparity appears to be a risk factor for treatment failure. In the retrospective study of 816 women described in the preceding paragraph, women with a parity of &ge;5 compared to &lt;5 had a six-fold increased risk of subsequent repeat endometrial ablation or hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Bleeding disorders or anticoagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coagulopathy due to bleeding disorders or anticoagulant medications is a potential etiology of heavy menstrual bleeding. Most methods of endometrial ablation are appropriate for use in such women. A retrospective cohort study compared 41 women with coagulopathy to 111 women with normal coagulation, all of whom underwent non-resectoscopic endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/51\">",
"     51",
"    </a>",
"    ]. Perioperative complications were infrequent in both groups; hematometra occurred in one woman with coagulopathy and in none of the controls. An average of two years after the procedure, rates of subsequent hysterectomy were similar for women with and without coagulopathy (5 and 7 percent).",
"   </p>",
"   <p>",
"    Endometrial resection should be avoided in women who have a bleeding disorder or are taking anticoagulants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Informed consent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who are considering endometrial ablation should be counseled about other medical, interventional radiologic, and surgical options for treatment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=see_link\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\"",
"    </a>",
"    .) It is important to advise women that a successful result is most likely to be a reduction in the volume of uterine bleeding, and amenorrhea is not guaranteed. In addition, endometrial ablation does not regulate bleeding in women with irregular patterns. The risks of persistent or recurrent heavy uterine bleeding and of surgical complications should be reviewed. This discussion should be documented on the surgical consent form and in the medical record (see",
"    <a class=\"local\" href=\"#H39\">",
"     'Outcome'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H33\">",
"     'Complications'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative evaluation, including perioperative risk assessment, is the same for endometrial ablation as for hysteroscopy. Pregnancy testing is performed; cervical cultures are appropriate if cervicitis is suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link&amp;anchor=H16#H16\">",
"     \"Overview of hysteroscopy\", section on 'Preoperative evaluation and preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Uterine evaluation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Endometrial sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial sampling is performed in all women prior to endometrial ablation to exclude endometrial hyperplasia or cancer. Ideally, this should be performed with enough time to receive the results and cancel the procedure, if neoplasia is found. However, if sampling has not yet been performed by the day of the procedure, it should be done just prior to the ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Assessment of the uterus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The uterine cavity should be assessed for the presence of intracavitary myomas, endometrial polyps, or other abnormalities (eg, uterine septum) that may interfere with endometrial ablation (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Leiomyomas or polyps'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H8\">",
"     'Uterine anomalies'",
"    </a>",
"    above). Some lesions can be removed hysteroscopically on the day of the procedure prior to performing the ablation. Women with a history of transmural uterine surgery (eg, cesarean delivery, myomectomy) should be evaluated for myometrial thinning (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Myometrial thinning following uterine surgery'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    We use saline infusion sonography (SIS) or office hysteroscopy to assess the uterine cavity. TVUS alone can identify uterine lesions, but does not define the contour of the cavity. In women in whom myometrial thinning is suspected, we use SIS. Alternatively, office hysteroscopy may be combined with transvaginal ultrasound (TVUS).",
"   </p>",
"   <p>",
"    In women with a large uterus on pelvic examination (&gt;10 weeks size), it is prudent to sound the uterus to assess cavity depth prior to planning an endometrial ablation (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Cavity size'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical preparation is the same as for hysteroscopy. If an intrauterine contraceptive device is in place, it should be removed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link&amp;anchor=H16#H16\">",
"     \"Overview of hysteroscopy\", section on 'Preoperative evaluation and preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Endometrial preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial pretreatment with hormonal agents is used by most surgeons prior to resectoscopic ablation (with the exception of endomyometrial resection) and is also advised by the manufacturers of most non-resectoscopic ablation devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/38,39,47,52\">",
"     38,39,47,52",
"    </a>",
"    ]. The goal of endometrial preparation is to thin the endometrium to facilitate tissue destruction.",
"   </p>",
"   <p>",
"    Hormonal suppression with a gonadotropin-releasing hormone (GnRH) agonist (eg, intramuscular",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/41/4760?source=see_link\">",
"     leuprolide",
"    </a>",
"    3.75",
"    <span class=\"nowrap\">",
"     mg/month)",
"    </span>",
"    is the most commonly used method of endometrial preparation prior to endometrial ablation. Hormonal pretreatment should be initiated 30 to 60 days prior to the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effectiveness of other hormonal agents for endometrial preparation prior to endometrial ablation is uncertain. Use of progestins (eg, oral",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    15 mg daily) instead of GnRH agonists offers the advantage of fewer adverse effects (eg, menopausal symptoms). Randomized trials comparing progestins or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/0/26629?source=see_link\">",
"     danazol",
"    </a>",
"    to GnRH agonists have found no difference in post-ablation improvement in uterine bleeding; however, these trials lacked statistical power [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. We prefer not to use danazol, since it is poorly tolerated by most women.",
"   </p>",
"   <p>",
"    There are few data regarding endometrial preparation with estrogen-progestin contraceptives or GnRH antagonists. Nonhormonal methods of preparation include: performing the procedure during the follicular phase of the menstrual cycle and uterine curettage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The benefits of hormonal suppression are well established for resectoscopic endometrial ablation, but not for non-resectoscopic ablation techniques. In a meta-analysis of 12 randomized trials of mostly resectoscopic ablation or resection (one trial used hot liquid filled balloon ablation), women in the GnRH agonist pretreatment group compared with placebo or no pretreatment had a shorter operative duration (an average of 4.8 minutes shorter) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/3\">",
"     3",
"    </a>",
"    ]. At one year after surgery, women in the GnRH agonist groups versus the no treatment groups had significantly lower rates of moderate or heavy menstrual bleeding (RR 0.7, 95% CI 0.6-0.9) and higher rates of amenorrhea (RR 1.6, 95% CI 1.2-2.0).",
"   </p>",
"   <p>",
"    Prior to non-resectoscopic endometrial ablation, current practice regarding endometrial preparation is based upon the device manufacturers' instructions. Pretreatment with GnRH agonists is advised by the manufacturers for all devices, with two exceptions. For hot liquid filled balloon ablation with the ThermaChoice&reg; device, the endometrium can be prepared with either hormonal suppression or curettage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/3\">",
"     3",
"    </a>",
"    ]. The other exception is bipolar radiofrequency ablation (Novasure&reg;), which does not require pretreatment since the device adjusts to differing tissue depths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/393?source=see_link\">",
"     \"Endometrial ablation: Non-resectoscopic techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Methods that do not require hormonal suppression offer the advantages of avoiding the one- to two-month pretreatment time and drug-related adverse effects (eg, menopausal symptoms). Randomized trials and observational data suggest that hot liquid balloon and microwave ablation may be performed successfully using alternative methods (eg, curettage or timing during the follicular phase of the menstrual cycle) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/57-60\">",
"     57-60",
"    </a>",
"    ]. As an example, five-year follow-up from a randomized trial of microwave endometrial ablation showed that women in whom the procedure was scheduled after menses compared with those who had preprocedure hormonal suppression had no significant differences in rates of amenorrhea (84 and 87 percent) or hysterectomy (11 and 6 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/60\">",
"     60",
"    </a>",
"    ]. Further study of this issue is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     OPERATIVE SETUP",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics are not routinely administered prior to endometrial ablation for prevention of surgical site infection or endocarditis since post-ablation infection is rare. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link&amp;anchor=H16#H16\">",
"     \"Overview of hysteroscopy\", section on 'Preoperative evaluation and preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resectoscopic ablation is usually performed with regional or general anesthesia. While there are reports of performing this type of ablation using local anesthesia, in our clinical experience, it is not well tolerated.",
"   </p>",
"   <p>",
"    Non-resectoscopic endometrial ablation can be performed using local, regional, or general anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/14,61,62\">",
"     14,61,62",
"    </a>",
"    ]. For procedures under local anesthesia, some surgeons also offer patients oral or intravenous conscious sedation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=see_link\">",
"     \"Procedural sedation in adults\"",
"    </a>",
"    .) General principles of anesthesia for endometrial ablation are the same as for operative hysteroscopy procedures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link&amp;anchor=H23#H23\">",
"     \"Overview of hysteroscopy\", section on 'Anesthesia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Administration of an oral nonsteroidal antiinflammatory drug (NSAID) at least one hour preoperatively is recommended by most non-resectoscopic device manufacturers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/14,56,63-66\">",
"     14,56,63-66",
"    </a>",
"    ]. NSAIDs may be useful to inhibit uterine contractions; however, regarding pain control in women receiving local anesthesia, randomized trial data show that NSAIDs given prior to operative hysteroscopy reduce postoperative, but not intraoperative, pain. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link&amp;anchor=H23#H23\">",
"     \"Overview of hysteroscopy\", section on 'Anesthesia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Local anesthesia with sedation was compared with general anesthesia in a randomized trial of 191 women undergoing microwave endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/67\">",
"     67",
"    </a>",
"    ]. Nine percent of procedures that started under local anesthesia were converted to general anesthesia due to patient discomfort. There were no significant differences between anesthetic groups regarding postoperative nausea, use of opiates, or recovery time. While tolerability was high overall, significantly fewer women who were assigned to local versus general anesthesia reported that the procedure was generally or totally acceptable (85 versus 97 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Office versus operating room procedures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resectoscopic endometrial ablation is performed in the operating room, since it typically requires regional or general anesthesia and close monitoring of irrigation fluid absorption. For laser techniques, the expense and size of the equipment preclude office use.",
"   </p>",
"   <p>",
"    Non-resectoscopic endometrial ablation has become an accepted office based procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/68\">",
"     68",
"    </a>",
"    ]. Endometrial ablation performed in the office offers the advantages of a familiar setting for the patient, easier scheduling, and lower procedural costs. The disadvantages of the office setting are the inability to switch to general anesthesia if the patient is not tolerating the procedure and the need to transfer the patient to an operating room if complications occur.",
"   </p>",
"   <p>",
"    In order to be candidates for office surgery, women should be at low risk for surgical or anesthesia complications. Physicians who offer ablation in the office need to be trained in administering and responding to complications of conscious sedation; assisting personnel must also be trained appropriately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/69\">",
"     69",
"    </a>",
"    ]. Emergency equipment must be available (eg, updated emergency cart, pulse oximeter, oxygen, wall suction) and protocols to handle rare complications such as excessive bleeding, uterine perforation, allergic reactions, or severe vagal reactions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=see_link\">",
"     \"Procedural sedation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Concomitant procedures",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Hysteroscopic myomectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women who have a submucosal leiomyoma, some surgeons perform a hysteroscopic myomectomy followed by endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. There are no safety data on the use of non-resectoscopic techniques in patients having a concurrent hysteroscopic myomectomy. In fact, prior uterine surgery is considered a contraindication for certain non-resectoscopic devices. If myomectomy is performed followed by ablation, we use only rollerball or endometrial resection techniques. Moreover, it is uncertain whether this procedure is more effective at improving uterine bleeding symptoms than myomectomy alone.",
"   </p>",
"   <p>",
"    Based on the available data, it appears that a combined procedure neither increases nor decreases the rate of subsequent hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. The only comparative study that evaluated myomectomy alone versus in combination with ablation was a retrospective cohort study of 177 women with submucosal fibroids and abnormal uterine bleeding; the combination of hysteroscopic myomectomy with endometrial ablation (rollerball or rollerbarrel method) or resection was associated with a significantly greater improvement in bleeding symptoms than myomectomy alone (96 versus 81 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/73\">",
"     73",
"    </a>",
"    ]. Further study is needed to establish whether a combined procedure impacts control of bleeding symptoms or operative complications.",
"   </p>",
"   <p>",
"    If a combined procedure is performed, it is prudent to perform the myomectomy followed by ablation or resection. Available studies have used resectoscopic methods, such as rollerball ablation or endometrial resection, rather than the non-resectoscopic ablation methods that are more commonly used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/74\">",
"     74",
"    </a>",
"    ]. However, resectoscopic methods may be preferable in this context. This is because they are performed under direct visualization, and the operator can avoid desiccating or resecting the endometrium or exposed myometrium that were attached to the myoma. This may avoid the spread of energy through areas of thin myometrium. In addition, non-resectoscopic devices have not been approved by the United States Food and Drug Administration for concomitant use with hysteroscopic myomectomy; the manufacturer of the microwave endometrial ablation system states that surgery that thins the myometrium should",
"    <strong>",
"     not",
"    </strong>",
"    be performed concurrently with ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/64\">",
"     64",
"    </a>",
"    ]. Hysteroscopic myomectomy is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32601?source=see_link\">",
"     \"Hysteroscopic myomectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H448471\">",
"    <span class=\"h3\">",
"     Sterilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concomitant endometrial ablation and hysteroscopic sterilization are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12665?source=see_link&amp;anchor=H19#H19\">",
"     \"Hysteroscopic sterilization\", section on 'Concomitant or subsequent procedures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Laparoscopic tubal occlusion can be performed concurrent with the ablation procedure, but there appears to be an increased risk of symptomatic cornual hematometra (see",
"    <a class=\"local\" href=\"#H37\">",
"     'Postablation tubal sterilization syndrome'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H448551\">",
"    <span class=\"h3\">",
"     Intrauterine device insertion",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few data regarding the placement of an intrauterine device (IUD) concomitant with or following endometrial ablation, thus the safety of this combination of procedures is not well established. Decisions regarding use of an IUD following endometrial ablation should be individualized.",
"   </p>",
"   <p>",
"    Transcervical resection of the endometrium (TCRE) with concomitant insertion of the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    -IUD (Mirena&reg;) appears to be safe and to result in a high rate of amenorrhea, based upon several small observational studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/75-77\">",
"     75-77",
"    </a>",
"    ]. The largest study was a retrospective cohort study of 53 women who underwent insertion of the levonorgestrel-IUD upon completion of endometrial resection and confirmation of adenomyosis; a control group of 42 women underwent endometrial resection only [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/77\">",
"     77",
"    </a>",
"    ]. All women received a prophylactic antibiotic postoperatively. At one-year follow-up, women in the levonorgestrel-IUD group had higher rates of amenorrhea (100 versus 9 percent) and resolution of dysmenorrhea (90 versus 20 percent). There were no complications in the IUD group that resulted in removal of the device. None of the women in the levonorgestrel-IUD group had a subsequent procedure to control uterine bleeding compared with eight women in the control group. There were no complications in the IUD group that resulted in removal of the device.",
"   </p>",
"   <p>",
"    There are no studies regarding placement of an IUD concomitant with or following non-resectoscopic endometrial ablation procedures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common complications associated with endometrial ablation are uterine perforation, hemorrhage, hematometra, and pelvic infection. Rates of complications of endometrial ablation reported in a meta-analysis of 21 randomized trials are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef71119 \" href=\"mobipreview.htm?3/40/3725\">",
"     table 2",
"    </a>",
"    ) and discussed below for each type of complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]. Other complications of endometrial ablation that are the same as those for operative hysteroscopy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link&amp;anchor=H37#H37\">",
"     \"Overview of hysteroscopy\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Major complications are rare. In the United States, the FDA has a voluntary reporting system for non-resectoscopic ablation complications. From 1990 to 2011, bowel injury (128 cases reported from 2005 to 2011) was the complication most commonly reported to the Manufacturer and User Facility Device (MAUDE) database [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/79-81\">",
"     79-81",
"    </a>",
"    ]. Circulating hot water ablation, in particular, was associated with burns to the vagina and perineum. Other major complications that were rarely reported included: urinary tract injury, perioperative hysterectomy, carbon dioxide embolism, necrotizing fasciitis, and death. It is not possible to calculate the rate of complications from these data, since the total number of procedures performed is not known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Uterine perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uterine perforation has been reported in 0.3 percent of non-resectoscopic endometrial ablation procedures and 1.3 percent of resectoscopic ablations or resections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]. The evaluation and management of uterine perforation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/19/4408?source=see_link\">",
"     \"Uterine perforation during gynecologic procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perioperative hemorrhage has been reported in 1.2 percent of women undergoing non-resectoscopic ablation and 3.0 percent of those undergoing resectoscopic ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]. Evaluation and management of hemorrhage are the same as for hysteroscopic procedures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=see_link&amp;anchor=H43#H43\">",
"     \"Overview of hysteroscopy\", section on 'Hemorrhage'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Hematometra",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrauterine scarring is an expected result of endometrial ablation. When areas of endometrium are adherent and there is endometrial bleeding behind the occlusion, hematometra will occur. The reported rate of hematometra in non-resectoscopic ablation is 0.9 percent and is 2.4 percent in resectoscopic ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hematometra should be suspected in a patient with a history of an endometrial ablation who presents with amenorrhea and cyclic pain, even remote from the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/82\">",
"     82",
"    </a>",
"    ]. This was supported by a study that found an association between postablation pain and a finding of hematometra in 19 women who underwent subsequent hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/83\">",
"     83",
"    </a>",
"    ]. Hematometra can be diagnosed with the visualization of pockets of echogenic fluid in the uterine cavity on transvaginal ultrasound.",
"   </p>",
"   <p>",
"    Uterine cavity occlusion is likely to occur in the cervical canal or at the most narrow portion of the endometrial cavity, the lower uterine segment. Thus, ablation of the cervix or cervico-uterine junction should be avoided. Complete ablation of the uterine fundus, cornua, and tubal ostia will also help avoid accumulation of blood from active endometrium.",
"   </p>",
"   <p>",
"    Cervical stenosis is treated with cervical dilation. Adhesions in the mid- to upper uterine cavity can be lysed under hysteroscopic guidance. For persistent pain caused by hematometra despite minimally invasive treatment, hysterectomy may be indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23048?source=see_link&amp;anchor=H23#H23\">",
"     \"Congenital cervical anomalies and benign cervical lesions\", section on 'Cervical stenosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/31/26101?source=see_link\">",
"     \"Intrauterine adhesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Postablation tubal sterilization syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some women who have undergone tubal ligation prior to endometrial ablation experience cyclic or intermittent pelvic pain. The proposed etiology is bleeding from active endometrium that is trapped in the uterine cornua. The incidence of this complication is as high as 10 percent in some reports [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/84\">",
"     84",
"    </a>",
"    ]. Prevention, diagnosis, and management of these symptoms are the same as for presentations of hematometra. In addition, some surgeons assess women with these symptoms laparoscopically and excise the tubal stumps to prevent the distension of the proximal tubal segments during menses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Pelvic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever occurs in the immediate postoperative period in approximately 1 percent of women who have undergone endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]. In the meta-analysis, the incidence of infectious complications included: endometritis (1.4 to 2.0 percent); myometritis (0 to 0.9 percent); pelvic inflammatory disease (1.1 percent); and pelvic abscess (0 to 1.1 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]. Evaluation and management of these infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/1/17431?source=see_link\">",
"     \"Endometritis unrelated to pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/63/35832?source=see_link\">",
"     \"Treatment of pelvic inflammatory disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36823?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcomes for non-resectoscopic and resectoscopic endometrial ablation are discussed here. Separate data for each of these types of ablation are given, where available. Outcomes for specific procedures (eg, rollerball ablation, cryoablation) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/393?source=see_link\">",
"     \"Endometrial ablation: Non-resectoscopic techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44708?source=see_link\">",
"     \"Endometrial ablation or resection: Resectoscopic techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h2\">",
"     Non-resectoscopic versus resectoscopic ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-resectoscopic and resectoscopic endometrial ablation result in comparable rates of amenorrhea and patient satisfaction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78,85\">",
"     78,85",
"    </a>",
"    ]. Resectoscopic endometrial ablation is associated with more frequent use of general anesthesia, a longer operative duration, and an increased risk of some surgical complications (eg, irrigation fluid overload). Technical skill requirements are another potential barrier to the use of resectoscopic ablation, since, currently, many surgeons are less experienced with these techniques. Resectoscopic techniques are less costly per procedure than non-resectoscopic ablation. In 2010, the cost of disposable equipment for resectoscopic procedures is approximately US $125 to $150, while the range for non-resectoscopic techniques is US $850 to $1300.",
"   </p>",
"   <p>",
"    Resectoscopic ablation is a reasonable option for surgeons with the required hysteroscopic skills. Resectoscopic ablation or therapy other than endometrial ablation may be optimal for women with acute flexion or version of the uterus that does not allow a non-resectoscopic ablation device to reach the uterine fundus or for women undergoing repeat endometrial ablation (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Uterine anomalies'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H55\">",
"     'Repeat endometrial ablation'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    The differences between non-resectoscopic and resectoscopic ablation were best demonstrated in a meta-analysis of 21 randomized trials (",
"    <a class=\"graphic graphic_table graphicRef71119 \" href=\"mobipreview.htm?3/40/3725\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]. Findings are discussed in the sections that follow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h3\">",
"     Improvement in bleeding symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women may experience irregular bleeding following endometrial ablation, so the success of the procedure cannot be determined until 8 to 12 weeks postoperatively. Most women with successful ablation will have a reduction in uterine blood flow, but not amenorrhea. There is variability across studies in whether menstrual blood loss was measured and the method used (eg, alkaline hematin method, pictorial blood assessment chart) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/86-88\">",
"     86-88",
"    </a>",
"    ]. Thus, amenorrhea, patient satisfaction, and subsequent surgery are more commonly used to assess treatment success.",
"   </p>",
"   <p>",
"    One example of the available data regarding reduction in menstrual blood flow is a randomized trial in which 279 women were assigned to Her Option&reg; cryoablation or rollerball ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/89\">",
"     89",
"    </a>",
"    ]. At 12-month follow-up, rates of normal menstrual flow (defined as a pictorial blood assessment chart score of &lt;75) were comparable for cryoablation and rollerball (85 and 89 percent).",
"   </p>",
"   <p>",
"    Regarding amenorrhea, in the meta-analysis of 21 trials, both non-resectoscopic and resectoscopic ablation resulted in similar rates of amenorrhea at one year (37 versus 38 percent, OR 0.9, 95% CI 0.6-1.4) and two to five years (53 versus 48 percent, OR 1.3, 95% CI 0.6-2.9) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h3\">",
"     Patient satisfaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient satisfaction rates were high for both types of ablation at one year (91 versus 88 percent, OR 1.2, 95% CI 0.9-1.7) and two to five years (93 versus 87 percent, OR 1.4, 95% CI 0.6-3.5) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h3\">",
"     Subsequent surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the meta-analysis, non-resectoscopic and resectoscopic ablation were associated with similar rates of additional surgical treatment for abnormal uterine bleeding at two to five years postoperatively for any type of surgery (including hysterectomy) (21 versus 25 percent, OR 0.9, 95% CI 0.6-1.4) and for hysterectomy alone (14 versus 19 percent, OR 0.8, 95% CI 0.5-1.3) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women who are less than 45 years old at the time of endometrial ablation appear to be at a higher risk of treatment failure than older women. This was illustrated in two retrospective studies (n = 816 and 3681) of women followed for five to eight years after endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/50,90\">",
"     50,90",
"    </a>",
"    ]. The risk of subsequent hysterectomy or repeat ablation was two-fold in women less than 45 years old versus those 45 years or older (54 versus 27 percent in one study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/90\">",
"     90",
"    </a>",
"    ]).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h3\">",
"     Complication rates",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following perioperative complications were significantly less likely following non-resectoscopic compared with resectoscopic ablation: irrigation fluid overload (0 versus 0.3 percent, OR 0.2, 95% CI 0.04-0.8), hematometra (0.9 versus 2.4 percent, OR 0.3, 95% CI 0.1-0.9), and cervical laceration (0.2 versus 2.2 percent, OR 0.2, 95% CI 0.1-0.6) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]. In addition, the rate of uterine perforation was lower, though this was not statistically significant (0.3 versus 1.3 percent, OR 0.3, 95% CI 0.1-1.0).",
"   </p>",
"   <p>",
"    Other types of complications for which the frequency did not differ significantly between types of ablation included: hemorrhage (1.2 versus 3.0 percent, OR 0.7, 95% CI 0.3-1.9) and endometritis (2.0 versus 1.4 percent, OR 1.3, 95% CI 0.4-3.6).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H45\">",
"    <span class=\"h3\">",
"     Anesthesia and technical factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;An advantage of non-resectoscopic compared with resectoscopic ablation is the greater likelihood of using local rather than general anesthesia (61 versus 21 percent, OR 6.4, 95% CI 3.0-13.7) and shorter operative duration (an average of 15 minutes shorter) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disadvantages of non-resectoscopic compared with resectoscopic ablation were a higher incidence of equipment failure (9.1 versus 1.6 percent),",
"    <span class=\"nowrap\">",
"     nausea/vomiting",
"    </span>",
"    (19 versus 7.7 percent), and uterine cramping (38 versus 33 percent).",
"   </p>",
"   <p>",
"    In addition to the factors listed above, resectoscopic ablation requires more technical skill than non-resectoscopic ablation. It is useful for a gynecologist who performs endometrial ablation to be trained in both types of ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46\">",
"    <span class=\"h3\">",
"     Cost",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-resectoscopic endometrial ablation devices are generally more expensive than the resectoscopic instruments used for rollerball ablation or wire loop resection. In addition, non-resectoscopic procedures are more commonly performed under local anesthesia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    in an office setting, which have lower procedural costs. Cost-utility model studies from the United Kingdom have reported that microwave and hot liquid filled balloon compared with resectoscopic ablation are less expensive and accrue more quality adjusted life years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/91,92\">",
"     91,92",
"    </a>",
"    ]. It is important to note that cost-utility calculations may vary in different health care settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H47\">",
"    <span class=\"h2\">",
"     Endometrial ablation versus other treatments",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48\">",
"    <span class=\"h3\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial resection was compared with medical therapy in a randomized trial that assigned 187 women with heavy menstrual bleeding to endometrial resection or oral medication (at least three cycles, specific medication varied) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/93\">",
"     93",
"    </a>",
"    ]. At four-month follow-up, days of heavy bleeding were significantly less in women treated with endometrial resection versus medication (0.8 versus 3.2 days). At five-year follow-up, the rate of hysterectomy was similar in women initially randomized to resection or medical therapy (18 and 19 percent); among women in the original medical therapy group, 10 percent still used medical treatment and 59 percent had surgical treatment other than hysterectomy. Further high quality data are needed to compare medical therapy with non-resectoscopic endometrial ablation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49\">",
"    <span class=\"h3\">",
"     Levonorgestrel-IUD",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to use the",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    intrauterine device or endometrial ablation depends upon a patient's preferences regarding treatment factors such as plans for fertility and contraception, convenience, and risks of anesthesia. Comparison between these two treatment options is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=see_link&amp;anchor=H30#H30\">",
"     \"Chronic menorrhagia or anovulatory uterine bleeding\", section on 'Choosing a long-term treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H50\">",
"    <span class=\"h3\">",
"     Hysterectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For most women who desire surgical therapy for heavy menstrual bleeding and who do not desire future pregnancy, we suggest endometrial ablation rather than hysterectomy. Rates of patient satisfaction and improvement in bleeding symptoms are high with both methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78,85\">",
"     78,85",
"    </a>",
"    ]. Hysterectomy is associated with a higher risk of perioperative complications, a longer recovery period, and greater expense. Of course, hysterectomy offers permanent relief from uterine bleeding and is a reasonable option in women who desire definitive therapy and who are willing to accept the risk of perioperative complications.",
"   </p>",
"   <p>",
"    Endometrial ablation and hysterectomy were compared in a meta-analysis of seven randomized trials. Mostly studies were of resectoscopic endometrial ablation methods (one trial used hot liquid balloon ablation); all surgical approaches for hysterectomy were included. Major findings were [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"     78",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The proportion of women with improvement in heavy uterine bleeding was high for both groups. The rate of improvement was significantly lower in women who underwent ablation versus hysterectomy at one year postoperatively (86 versus 100 percent; OR 0.04, 95% CI 0.01-0.2). However, based on single trials, there were no significant differences in symptomatic relief at two and four years after surgery.",
"     </li>",
"     <li>",
"      Patient satisfaction rates at two years postoperatively were high for both procedures. At two years postoperatively, satisfaction rates were lower among women in the ablation versus hysterectomy group (71 versus 79 percent, OR 0.5, 95% CI 0.3-0.8). However, at four years, the difference approached, but did not reach, significance (68 versus 76 percent, OR 0.6, 95% CI 0.3-1.1).",
"     </li>",
"     <li>",
"      Several perioperative complications were significantly less frequent with ablation, including: blood transfusion (0.7 versus 4.5 percent) and infection (5.2 versus 32 percent). The rate of post-hysterectomy infection in this study was much higher than the usual reported rate. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32490?source=see_link&amp;anchor=H1745635#H1745635\">",
"       \"Abdominal hysterectomy\", section on 'Infection'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Following ablation, hospital stay was shorter and return to daily activities was an average of 11.3 days shorter.",
"     </li>",
"     <li>",
"      The total cost of endometrial ablation was significantly lower than the cost of hysterectomy. However, the difference between the two procedures narrowed over time because of the cost of subsequent treatment in women with unsuccessful ablation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional data regarding the comparative costs of ablation versus hysterectomy were reported in a cost-utility model study from the United Kingdom. For 1000 women over a period of 10 years, microwave and hot liquid filled balloon compared with hysterectomy were less expensive (1.3 and 1.4 versus 2.3 million British pounds) and accrued more quality adjusted life years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/91\">",
"     91",
"    </a>",
"    ]. It is important to note that cost-utility calculations may vary in different health care settings.",
"   </p>",
"   <p>",
"    In general, studies have found no detrimental effects of hysterectomy on sexual function. However, some data suggest that these effects occur more frequently following hysterectomy than endometrial ablation. This was illustrated in a population-based prospective cohort study of over 9500 women who underwent either endometrial resection or hysterectomy (total or subtotal) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/94\">",
"     94",
"    </a>",
"    ]. Oophorectomy versus no oophorectomy at time of hysterectomy was associated with a greater adverse effect on sexual function; therefore, data are included only for women whose ovaries were conserved. At five-year follow-up, women who underwent hysterectomy without oophorectomy versus endometrial resection had significantly higher age- and hormone therapy-adjusted rates of severe effects on sexual measures: loss of libido (OR 1.4, 95% CI 1.2-1.7); difficult sexual arousal (OR 1.4, 95% CI 1.2-1.6); and vaginal dryness (OR 1.5, 95% CI 1.2-1.9). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12602?source=see_link&amp;anchor=H17#H17\">",
"     \"Overview of hysterectomy\", section on 'Psychosexual issues'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H51\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H52\">",
"    <span class=\"h2\">",
"     Routine postoperative care",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common postoperative side effects of endometrial ablation are cramping and vaginal discharge. Light vaginal bleeding or pink-tinged discharge is often present for two to three days. Uterine cramping may persist for 24 to 72 hours. Most women can resume normal activities in one to three days.",
"   </p>",
"   <p>",
"    We give patients routine post-hysteroscopy instructions. We counsel patients to call if they have severe or persistent pelvic pain or vaginal bleeding. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/27/28083?source=see_link\">",
"     \"Patient information: Care after gynecologic surgery (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, women who have undergone endometrial ablation must be counseled about the need for contraception.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H53\">",
"    <span class=\"h2\">",
"     Recurrent abnormal uterine bleeding",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H54\">",
"    <span class=\"h3\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who have undergone endometrial ablation may have irregular uterine bleeding or spotting. However, such symptoms should not be presumed to be a normal outcome of ablation. Women who develop irregular, excessive, or prolonged uterine bleeding following endometrial ablation should undergo endometrial sampling to exclude endometrial neoplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55\">",
"    <span class=\"h3\">",
"     Repeat endometrial ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For some women in whom abnormal uterine bleeding recurs after ablation, a repeat ablation may be beneficial. Rates of re-ablation of approximately 5 to 20 percent have been reported within three to five years of the initial procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/93,95-100\">",
"     93,95-100",
"    </a>",
"    ]. Although repeat non-resectoscopic ablation procedures have been reported, we use only resectoscopic ablation for repeat procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/99\">",
"     99",
"    </a>",
"    ]. This is because the uterine cavity is likely to be distorted and hysteroscopic visualization makes it possible to identify and treat remaining areas of endometrium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Complication rates (eg, uterine perforation, excessive fluid absorption, genital tract burns) were higher in repeat compared with primary ablations in a retrospective cohort study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H56\">",
"    <span class=\"h2\">",
"     Pregnancy after ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite destruction of the endometrium, pregnancy occurs in 0.7 percent of women who have undergone endometrial ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/5\">",
"     5",
"    </a>",
"    ]. While successful pregnancies have been reported, there appears to be greater risk of complications in pregnancies that follow ablation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/101-104\">",
"     101-104",
"    </a>",
"    ]. Data are limited regarding obstetric outcomes; a review of 74 cases reported the following: pregnancy termination (38 percent); ectopic pregnancy (3 percent); first trimester miscarriage (12 percent); second trimester pregnancy loss (5 percent); preterm delivery (20 percent); and term delivery (20 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/5\">",
"     5",
"    </a>",
"    ]. Another literature review of 70 cases reported rates of abnormal placentation (26 percent), malpresentation (39 percent), and perinatal mortality (13 percent); 71 percent of women underwent cesarean delivery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/7/31866/abstract/105\">",
"     105",
"    </a>",
"    ]. Further study is needed to evaluate the risk of obstetric complications in post-ablation pregnancies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H57\">",
"    <span class=\"h2\">",
"     Use of postmenopausal hormone therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who have had an endometrial ablation and later choose to use postmenopausal hormone therapy should be given progestins along with estrogen for endometrial cancer protection of any untreated endometrial tissue. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=see_link&amp;anchor=H256690730#H256690730\">",
"     \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Protective effect of progestins'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/8/143?source=see_link\">",
"       \"Patient information: Endometrial ablation (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H58\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endometrial ablation is the surgical destruction of the endometrium for the treatment of abnormal uterine bleeding. Resectoscopic ablation is performed under hysteroscopic visualization, using resectoscopic instruments to ablate or resect the endometrium. Non-resectoscopic ablation is performed with a disposable device which is inserted into the uterine cavity and delivers energy to uniformly destroy the uterine lining. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Terminology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy is contraindicated following endometrial ablation, but ablation does not prevent pregnancy. Contraception is still necessary after ablation in sexually active women. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Desire to preserve fertility'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endometrial ablation is not appropriate in women with endometrial hyperplasia or cancer. Endometrial sampling should be performed in all women prior to ablation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Endometrial hyperplasia or cancer'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Endometrial sampling'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest not performing endometrial ablation in postmenopausal women (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). It may be difficult to adequately evaluate postmenopausal bleeding in patients who have undergone ablation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Postmenopausal women'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some, but not all, of the non-resectoscopic ablation devices have been evaluated for use in women with small submucosal fibroids. It appears that endometrial ablation in these women is less effective than in women with a normal uterine cavity. Fibroids are typically removed prior to performing resectoscopic ablation or resection. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Leiomyomas or polyps'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women undergoing endometrial ablation with most non-resectoscopic devices, we suggest endometrial preparation rather than no preparation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The exception is bipolar radiofrequency ablation, which does not require endometrial preparation. Either hormonal suppression or uterine curettage can be used for endometrial preparation for hot liquid filled balloon ablation. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Endometrial preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women undergoing most types of resectoscopic endometrial ablation, we recommend endometrial preparation over no endometrial preparation (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Endometrial preparation is not necessary prior to endometrial resection. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Endometrial preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For endometrial preparation with hormonal suppression prior to endometrial ablation, we suggest gonadotropin-releasing agonists over other agents (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Pretreatment with oral contraceptives is used by some surgeons. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Endometrial preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The choice of resectoscopic or non-resectoscopic ablation must be individualized to the patient and the surgeon's familiarity with the procedure. Both approaches to endometrial ablation result in comparable rates of amenorrhea and patient satisfaction. Resectoscopic endometrial ablation is associated with more frequent use of general anesthesia, a longer operative duration, and an increased risk of some surgical complications (eg, irrigation fluid overload). Resectoscopic techniques are less costly per procedure and may be optimal for women with acute flexion or version of the uterus that does not allow a non-resectoscopic ablation device to reach the uterine fundus or for women undergoing repeat endometrial ablation. (See",
"      <a class=\"local\" href=\"#H40\">",
"       'Non-resectoscopic versus resectoscopic ablation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Resectoscopic ablation is usually performed with regional or general anesthesia. Non-resectoscopic endometrial ablation can be performed using local, regional, or general anesthesia. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Anesthesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with chronic anovulation often find chronic medical therapy cumbersome due to daily or weekly dosing. In such women, we suggest the",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?24/47/25336?source=see_link\">",
"       levonorgestrel",
"      </a>",
"      intrauterine device rather than endometrial ablation (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Endometrial ablation is a reasonable choice in women who do not desire future pregnancy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      wish to avoid using or changing an intrauterine device. (See",
"      <a class=\"local\" href=\"#H49\">",
"       'Levonorgestrel-IUD'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=see_link&amp;anchor=H30#H30\">",
"       \"Chronic menorrhagia or anovulatory uterine bleeding\", section on 'Choosing a long-term treatment'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For most women who desire surgical therapy for abnormal uterine bleeding and who do not desire future pregnancy, we suggest endometrial ablation or minimally invasive hysterectomy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Hysterectomy is a reasonable option in women who desire definitive therapy and who are willing to accept the risk of perioperative complications. (See",
"      <a class=\"local\" href=\"#H50\">",
"       'Hysterectomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women who have had an endometrial ablation and later choose to use postmenopausal hormone therapy require endometrial protection with progestins. (See",
"      <a class=\"local\" href=\"#H57\">",
"       'Use of postmenopausal hormone therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/1\">",
"      Cromwell DA, Mahmood TA, Templeton A, van der Meulen JH. Surgery for menorrhagia within English regions: variation in rates of endometrial ablation and hysterectomy. BJOG 2009; 116:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/2\">",
"      Deb S, Flora K, Atiomo W. A survey of preferences and practices of endometrial ablation/resection for menorrhagia in the United Kingdom. Fertil Steril 2008; 90:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/3\">",
"      Sharp HT. Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata. Obstet Gynecol 2006; 108:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/4\">",
"      ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 81, May 2007. Obstet Gynecol 2007; 109:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/5\">",
"      Lo JS, Pickersgill A. Pregnancy after endometrial ablation: English literature review and case report. J Minim Invasive Gynecol 2006; 13:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/6\">",
"      Xia E, Li TC, Yu D, et al. The occurrence and outcome of 39 pregnancies after 1621 cases of transcervical resection of endometrium. Hum Reprod 2006; 21:3282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/7\">",
"      Ammar K, Koukoura O. Management of menorrhagia with hydrothermal endometrial ablation in 2 women with bicornuate uteri. J Minim Invasive Gynecol 2009; 16:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/8\">",
"      Thamban S, Garg S, Al-Habib A, El-Farra KE. Thermal balloon endometrial ablation in bicornuate uteri. J Obstet Gynaecol 2007; 27:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/9\">",
"      Zarek S, Sharp HT. Global endometrial ablation devices. Clin Obstet Gynecol 2008; 51:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/10\">",
"      Gangadharan A, Revel A, Shushan A. Endometrial thermal balloon ablation in women with previous cesarean delivery: pilot study. J Minim Invasive Gynecol 2010; 17:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/11\">",
"      Khan Z, El-Nashar SA, Hopkins MR, Famuyide AO. Efficacy and safety of global endometrial ablation after cesarean delivery: a cohort study. Am J Obstet Gynecol 2011; 205:450.e1.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/cdrh_docs/pdf2/P020031b.pdf. (Accessed May 26, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/13\">",
"      Lissak A, Lavie O, Dirnfeld M, et al. Endometrial ablation for the postmenopausal woman. J Am Assoc Gynecol Laparosc 2001; 8:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/14\">",
"      Practice Committee of American Society for Reproductive Medicine. Indications and options for endometrial ablation. Fertil Steril 2008; 90:S236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/15\">",
"      Neuwirth RS, Loffer FD, Trenhaile T, Levin B. The incidence of endometrial cancer after endometrial ablation in a low-risk population. J Am Assoc Gynecol Laparosc 2004; 11:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/16\">",
"      Krogh RA, Lauszus FF, Guttorm E, Rasmussen K. Surgery and cancer after endometrial resection. Long-term follow-up on menstrual bleeding and hormone treatment by questionnaire and registry. Arch Gynecol Obstet 2009; 280:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/17\">",
"      Gimpelson RJ. Not so benign endometrial hyperplasia: endometrial cancer after endometrial ablation. J Am Assoc Gynecol Laparosc 1997; 4:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/18\">",
"      Horowitz IR, Copas PR, Aaronoff M, et al. Endometrial adenocarcinoma following endometrial ablation for postmenopausal bleeding. Gynecol Oncol 1995; 56:460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/19\">",
"      Valle RF, Baggish MS. Endometrial carcinoma after endometrial ablation: high-risk factors predicting its occurrence. Am J Obstet Gynecol 1998; 179:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/20\">",
"      Sagiv R, Ben-Shem E, Condrea A, et al. Endometrial carcinoma after endometrial resection for dysfunctional uterine bleeding. Obstet Gynecol 2005; 106:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/21\">",
"      Baggish, MS, Ringgenberg, E, Sze, EHM. Adenocarcinoma of corpus uteri following endometrial ablation. J Gynecol Surg 1995; 11:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/22\">",
"      Iqbal PK, Paterson ME. Endometrial carcinoma after endometrial resection for menorrhagia. Br J Obstet Gynaecol 1997; 104:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/23\">",
"      Brooks-Carter GN, Killackey MA, Neuwirth RS. Adenocarcinoma of the endometrium after endometrial ablation. Obstet Gynecol 2000; 96:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/24\">",
"      Margolis MT, Thoen LD, Boike GM, et al. Asymptomatic endometrial carcinoma after endometrial ablation. Int J Gynaecol Obstet 1995; 51:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/25\">",
"      Klein, Z, Markovitch, O, Altaras, M, et al. Advanced endometrial adenocarcinoma following endometrial ablation: a case report and review of the literature. Int J Gynecol Cancer 1997; 7:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/26\">",
"      Friberg B, Joergensen C, Ahlgren M. Endometrial thermal coagulation--degree of uterine fibrosis predicts treatment outcome. Gynecol Obstet Invest 1998; 45:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/27\">",
"      Leung PL, Tam WH, Yuen PM. Hysteroscopic appearance of the endometrial cavity following thermal balloon endometrial ablation. Fertil Steril 2003; 79:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/28\">",
"      Taskin O, Onoglu A, Inal M, et al. Long-term histopathologic and morphologic changes after thermal endometrial ablation. J Am Assoc Gynecol Laparosc 2002; 9:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/29\">",
"      Onoglu A, Taskin O, Inal M, et al. Comparison of the long-term histopathologic and morphologic changes after endometrial rollerball ablation and resection: a prospective randomized trial. J Minim Invasive Gynecol 2007; 14:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/30\">",
"      Ahonkallio SJ, Liakka AK, Martikainen HK, Santala MJ. Feasibility of endometrial assessment after thermal ablation. Eur J Obstet Gynecol Reprod Biol 2009; 147:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/31\">",
"      Copperman AB, DeCherney AH, Olive DL. A case of endometrial cancer following endometrial ablation for dysfunctional uterine bleeding. Obstet Gynecol 1993; 82:640.",
"     </a>",
"    </li>",
"    <li>",
"     Kindelberger, D, Harvard University School of Medicine, 2010, personal communication.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/33\">",
"      AlHilli MM, Hopkins MR, Famuyide AO. Endometrial cancer after endometrial ablation: systematic review of medical literature. J Minim Invasive Gynecol 2011; 18:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/34\">",
"      Capuano I, Caporale A, Vagnetti P, et al. [Endometrial ablation versus hysterectomy in women treated with tamoxifen]. Minerva Ginecol 2007; 59:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/35\">",
"      Goldenberg M, Nezhat C, Seidman DS. A randomized prospective study of the use of endometrial ablation for prevention of recurrent endometrial polyps in breast cancer patients receiving tamoxifen. Prim Care Update Ob Gyns 1998; 5:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/36\">",
"      R&ouml;mer T. Successful treatment of recurrent uterine bleeding during tamoxifen therapy by endometrial ablation. Int J Gynaecol Obstet 1995; 49:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/37\">",
"      Fadare O, Wang SA, Renshaw IL. Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases. Diagn Pathol 2008; 3:28.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p020031 (Microwave Endometrial Ablation). (Accessed Accessed June 9, 2010).",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p000032 (Her Option). (Accessed June 9, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/40\">",
"      Cooper JM, Anderson TL, Fortin CA, et al. Microwave endometrial ablation vs. rollerball electroablation for menorrhagia: a multicenter randomized trial. J Am Assoc Gynecol Laparosc 2004; 11:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/41\">",
"      Glasser, MH, Heinlein, PK, Hung, YY. Office endometrial ablation with local anesthesia using the hydrothermablator system: comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5 1/ 2 years. J Minim Invas Gynecol 2010; 16:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/42\">",
"      Glasser MH, Zimmerman JD. The HydroThermAblator system for management of menorrhagia in women with submucous myomas: 12- to 20-month follow-up. J Am Assoc Gynecol Laparosc 2003; 10:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/43\">",
"      Rosenbaum SP, Fried M, Munro MG. Endometrial hydrothermablation: a comparison of short-term clinical effectiveness in patients with normal endometrial cavities and those with intracavitary pathology. J Minim Invasive Gynecol 2005; 12:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/44\">",
"      Sabbah R, Desaulniers G. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study. J Minim Invasive Gynecol 2006; 13:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/45\">",
"      Soysal ME, Soysal SK, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia. Gynecol Obstet Invest 2001; 51:128.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p010013 (Novasure). (Accessed June 9, 2010).",
"    </li>",
"    <li>",
"     www.ethicon360.com/products/gynecare-thermachoice-uterine-balloon-therapy-system. (Accessed Accessed June 9, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/48\">",
"      McCausland AM, McCausland VM. Partial rollerball endometrial ablation: a modification of total ablation to treat menorrhagia without causing complications from intrauterine adhesions. Am J Obstet Gynecol 1999; 180:1512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/49\">",
"      Bae IH, Pagedas AC. Comparison of Partial and Complete Endomyometrial Resection with Rollerball Endometrial Ablation. J Am Assoc Gynecol Laparosc 1996; 3:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/50\">",
"      El-Nashar SA, Hopkins MR, Creedon DJ, et al. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol 2009; 113:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/51\">",
"      El-Nashar SA, Hopkins MR, Feitoza SS, et al. Global endometrial ablation for menorrhagia in women with bleeding disorders. Obstet Gynecol 2007; 109:1381.",
"     </a>",
"    </li>",
"    <li>",
"     file://74.125.47.132/search?q=cache:8V53ZDQy8K0J:www.accessdata.fda.gov/cdrh_docs/pdf/P000040c.pdf+fda+hydrothermablator&amp;cd=1&amp;hl=en&amp;ct=clnk&amp;gl=us&amp;client=firefox-a. (Accessed June 9, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/53\">",
"      Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database Syst Rev 2002; :CD001124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/54\">",
"      Shawki O, Peters A, Abraham-Hebert S. Hysteroscopic endometrial destruction, optimum method for preoperative endometrial preparation: a prospective, randomized, multicenter evaluation. JSLS 2002; 6:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/55\">",
"      Bhatia K, Doonan Y, Giannakou A, Bentick B. A randomised controlled trial comparing GnRH antagonist cetrorelix with GnRH agonist leuprorelin for endometrial thinning prior to transcervical resection of endometrium. BJOG 2008; 115:1214.",
"     </a>",
"    </li>",
"    <li>",
"     www.novasure.com/novasure-procedure/novasure-instructions.cfm (Accessed February 16, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/57\">",
"      Lissak A, Fruchter O, Mashiach S, et al. Immediate versus delayed treatment of perimenopausal bleeding due to benign causes by balloon thermal ablation. J Am Assoc Gynecol Laparosc 1999; 6:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/58\">",
"      Huang MC, Chen CP, Su TH, et al. The safety and efficacy of microwave endometrial ablation after endometrial curettage without hormonal pretreatment. Taiwan J Obstet Gynecol 2007; 46:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/59\">",
"      Jack SA, Cooper KG, Seymour J, et al. A randomised controlled trial of microwave endometrial ablation without endometrial preparation in the outpatient setting: patient acceptability, treatment outcome and costs. BJOG 2005; 112:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/60\">",
"      Sambrook AM, Jack SA, Cooper KG. Outpatient microwave endometrial ablation: 5-year follow-up of a randomised controlled trial without endometrial preparation versus standard day surgery with endometrial preparation. BJOG 2010; 117:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/61\">",
"      Glasser MH, Heinlein PK, Hung YY. Office endometrial ablation with local anesthesia using the HydroThermAblator system: Comparison of outcomes in patients with submucous myomas with those with normal cavities in 246 cases performed over 5(1/2) years. J Minim Invasive Gynecol 2009; 16:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/62\">",
"      Chapa HO. Utility of in-office endometrial ablation: a prospective cohort study of endometrial ablation under local anesthesia. J Reprod Med 2008; 53:827.",
"     </a>",
"    </li>",
"    <li>",
"     file://74.125.47.132/search?q=cache:8V53ZDQy8K0J:www.accessdata.fda.gov/cdrh_docs/pdf/P000040c.pdf+fda+hydrothermablator&amp;cd=1&amp;hl=en&amp;ct=clnk&amp;gl=us&amp;client=firefox-a (Accessed February 16, 2010).",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p020031 (Accessed February 16, 2010).",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cftopic/pma/pma.cfm?num=p000032 (Accessed February 16, 2010).",
"    </li>",
"    <li>",
"     www.ethicon360.com/products/gynecare-thermachoice-uterine-balloon-therapy-system (Accessed February 16, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/67\">",
"      Wallage S, Cooper KG, Graham WJ, Parkin DE. A randomised trial comparing local versus general anaesthesia for microwave endometrial ablation. BJOG 2003; 110:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/68\">",
"      Glasser MH. Practical tips for office hysteroscopy and second-generation \"global\" endometrial ablation. J Minim Invasive Gynecol 2009; 16:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/69\">",
"      Erickson TB, Kirkpatrick DH, DeFrancesco MS, Lawrence HC 3rd. Executive summary of the American College of Obstetricians and Gynecologists Presidential Task Force on Patient Safety in the Office Setting: reinvigorating safety in office-based gynecologic surgery. Obstet Gynecol 2010; 115:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/70\">",
"      Polena V, Mergui JL, Perrot N, et al. Long-term results of hysteroscopic myomectomy in 235 patients. Eur J Obstet Gynecol Reprod Biol 2007; 130:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/71\">",
"      Glasser MH. Endometrial ablation and hysteroscopic myomectomy by electrosurgical vaporization. J Am Assoc Gynecol Laparosc 1997; 4:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/72\">",
"      Rovio PH, Helin R, Heinonen PK. Long-term outcome of hysteroscopic endometrial resection with or without myomectomy in patients with menorrhagia. Arch Gynecol Obstet 2009; 279:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/73\">",
"      Loffer FD. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation. J Minim Invasive Gynecol 2005; 12:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/74\">",
"      Loffer FD. Endometrial ablation in patients with myomas. Curr Opin Obstet Gynecol 2006; 18:391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/75\">",
"      Low S, Smith K. TCRE and Mirena: Is the combination better? Gynecol Surg 2006; 3:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/76\">",
"      Basama FMS, Muppala H, Inglis TCM. Re-audit: Transcervical resection of the endometrium for heavy menstrual bleeding and the treatment of post-resection uterine stenosis and hematometra by cervical dilation and the insertion of a levonorgestrel-releasing intra-uterine system. Gynecol Surg 2007; 4:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/77\">",
"      Maia H Jr, Maltez A, Coelho G, et al. Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc 2003; 10:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/78\">",
"      Lethaby A, Hickey M, Garry R, Penninx J. Endometrial resection / ablation techniques for heavy menstrual bleeding. Cochrane Database Syst Rev 2009; :CD001501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/79\">",
"      Della Badia C, Nyirjesy P, Atogho A. Endometrial ablation devices: review of a manufacturer and user facility device experience database. J Minim Invasive Gynecol 2007; 14:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/80\">",
"      Gurtcheff SE, Sharp HT. Complications associated with global endometrial ablation: the utility of the MAUDE database. Obstet Gynecol 2003; 102:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/81\">",
"      Brown J, Blank K. Minimally invasive endometrial ablation device complications and use outside of the manufacturers' instructions. Obstet Gynecol 2012; 120:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/82\">",
"      McCausland AM, McCausland VM. Long-term complications of endometrial ablation: cause, diagnosis, treatment, and prevention. J Minim Invasive Gynecol 2007; 14:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/83\">",
"      Carey ET, El-Nashar SA, Hopkins MR, et al. Pathologic characteristics of hysterectomy specimens in women undergoing hysterectomy after global endometrial ablation. J Minim Invasive Gynecol 2011; 18:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/84\">",
"      McCausland AM, McCausland VM. Frequency of symptomatic cornual hematometra and postablation tubal sterilization syndrome after total rollerball endometrial ablation: a 10-year follow-up. Am J Obstet Gynecol 2002; 186:1274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/85\">",
"      Middleton LJ, Champaneria R, Daniels JP, et al. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 2010; 341:c3929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/86\">",
"      Newton JR, Reading AE. The effects of psychological preparation on pain at intrauterine device insertion. Contraception 1977; 16:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/87\">",
"      Lekander M, von Essen J, Schultzberg M, et al. Cytokines and memory across the mature life span of women. Scand J Psychol 2011; 52:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/88\">",
"      Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/89\">",
"      Duleba AJ, Heppard MC, Soderstrom RM, Townsend DE. A randomized study comparing endometrial cryoablation and rollerball electroablation for treatment of dysfunctional uterine bleeding. J Am Assoc Gynecol Laparosc 2003; 10:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/90\">",
"      Longinotti MK, Jacobson GF, Hung YY, Learman LA. Probability of hysterectomy after endometrial ablation. Obstet Gynecol 2008; 112:1214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/91\">",
"      Garside R, Stein K, Wyatt K, et al. A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG 2004; 111:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/92\">",
"      Clegg JP, Guest JF, Hurskainen R. Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK. Curr Med Res Opin 2007; 23:1637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/93\">",
"      Cooper KG, Jack SA, Parkin DE, Grant AM. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG 2001; 108:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/94\">",
"      McPherson K, Herbert A, Judge A, et al. Psychosexual health 5 years after hysterectomy: population-based comparison with endometrial ablation for dysfunctional uterine bleeding. Health Expect 2005; 8:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/95\">",
"      MacLean-Fraser E, Penava D, Vilos GA. Perioperative complication rates of primary and repeat hysteroscopic endometrial ablations. J Am Assoc Gynecol Laparosc 2002; 9:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/96\">",
"      F&uuml;rst SN, Philipsen T, Joergensen JC. Ten-year follow-up of endometrial ablation. Acta Obstet Gynecol Scand 2007; 86:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/97\">",
"      O'Connor H, Magos A. Endometrial resection for the treatment of menorrhagia. N Engl J Med 1996; 335:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/98\">",
"      A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Aberdeen Endometrial Ablation Trials Group. Br J Obstet Gynaecol 1999; 106:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/99\">",
"      Loffer FD, Grainger D. Five-year follow-up of patients participating in a randomized trial of uterine balloon therapy versus rollerball ablation for treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002; 9:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/100\">",
"      Tsaltas J, Taylor N, Healey M. A 6-year review of the outcome of endometrial ablation. Aust N Z J Obstet Gynaecol 1998; 38:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/101\">",
"      Foote M, Rouse A, Gil KM, et al. Successful pregnancy following both endometrial ablation and uterine artery embolization. Fertil Steril 2007; 88:1676.e15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/102\">",
"      Laberge PY. Serious and deadly complications from pregnancy after endometrial ablation: two case reports and review of the literature. J Gynecol Obstet Biol Reprod (Paris) 2008; 37:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/103\">",
"      Bowling MR, Ramsey PS. Spontaneous uterine rupture in pregnancy after endometrial ablation. Obstet Gynecol 2010; 115:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/104\">",
"      Kuzel D, Bartosova L, Rezabek K, et al. Successful pregnancy after thermal balloon endometrial ablation followed by in vitro fertilization and embryo transfer. Fertil Steril 2010; 93:1006.e11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/7/31866/abstract/105\">",
"      Hare AA, Olah KS. Pregnancy following endometrial ablation: a review article. J Obstet Gynaecol 2005; 25:108.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3316 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.166.191.243-DB525E7F52-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31866=[""].join("\n");
var outline_f31_7_31866=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H58\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Endometrial hyperplasia or cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Desire to preserve fertility",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Uterine anomalies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Myometrial thinning following uterine surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Special considerations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Risk factors for endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Leiomyomas or polyps",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Cavity size",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Adenomyosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Parity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Bleeding disorders or anticoagulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PREOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Informed consent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Uterine evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Endometrial sampling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Assessment of the uterus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Endometrial preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      OPERATIVE SETUP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Office versus operating room procedures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Concomitant procedures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Hysteroscopic myomectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H448471\">",
"      - Sterilization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H448551\">",
"      - Intrauterine device insertion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Uterine perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Hematometra",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Postablation tubal sterilization syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Pelvic infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      Non-resectoscopic versus resectoscopic ablation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      - Improvement in bleeding symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      - Patient satisfaction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      - Subsequent surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      - Complication rates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H45\">",
"      - Anesthesia and technical factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H46\">",
"      - Cost",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H47\">",
"      Endometrial ablation versus other treatments",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H48\">",
"      - Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H49\">",
"      - Levonorgestrel-IUD",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H50\">",
"      - Hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H51\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H52\">",
"      Routine postoperative care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H53\">",
"      Recurrent abnormal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H54\">",
"      - Evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H55\">",
"      - Repeat endometrial ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H56\">",
"      Pregnancy after ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H57\">",
"      Use of postmenopausal hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H58\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3316\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3316|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?43/27/44465\" title=\"figure 1\">",
"      Endometrium layers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3316|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/30/39403\" title=\"table 1\">",
"      Risk factors endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/40/3725\" title=\"table 2\">",
"      Outcome of endometrial ablation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32490?source=related_link\">",
"      Abdominal hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/41/20122?source=related_link\">",
"      Chronic menorrhagia or anovulatory uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/32/23048?source=related_link\">",
"      Congenital cervical anomalies and benign cervical lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/34/40486?source=related_link\">",
"      Continuous postmenopausal hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/42/44708?source=related_link\">",
"      Endometrial ablation or resection: Resectoscopic techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/24/393?source=related_link\">",
"      Endometrial ablation: Non-resectoscopic techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18233?source=related_link\">",
"      Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=related_link\">",
"      Endometrial carcinoma: Epidemiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/10/7336?source=related_link\">",
"      Endometrial polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/1/17431?source=related_link\">",
"      Endometritis unrelated to pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/61/36823?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of tuboovarian abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=related_link\">",
"      Evaluation of the endometrium for malignant or premalignant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/47/3832?source=related_link\">",
"      Hormonal contraception for suppression of menstruation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32601?source=related_link\">",
"      Hysteroscopic myomectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/23/12665?source=related_link\">",
"      Hysteroscopic sterilization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/31/26101?source=related_link\">",
"      Intrauterine adhesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/2/11305?source=related_link\">",
"      Managing an episode of severe or prolonged uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/19/12602?source=related_link\">",
"      Overview of hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/17/9498?source=related_link\">",
"      Overview of hysteroscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/27/28083?source=related_link\">",
"      Patient information: Care after gynecologic surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/8/143?source=related_link\">",
"      Patient information: Endometrial ablation (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/41/2711?source=related_link\">",
"      Postmenopausal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/51/34618?source=related_link\">",
"      Procedural sedation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/63/35832?source=related_link\">",
"      Treatment of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/19/4408?source=related_link\">",
"      Uterine perforation during gynecologic procedures",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_7_31867="Prevalence antithyroid Ab";
var content_f31_7_31867=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F76522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F76522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated prevalence of antithyroid antibodies (in percent)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Group",
"       </td>",
"       <td class=\"subtitle1\">",
"        Anti-TSHR Ab",
"       </td>",
"       <td class=\"subtitle1\">",
"        Anti-Tg Ab",
"       </td>",
"       <td class=\"subtitle1\">",
"        Anti-TPO Ab",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        General population",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        5 to 20",
"       </td>",
"       <td>",
"        8 to 27",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Graves' disease",
"       </td>",
"       <td>",
"        80 to 95",
"       </td>",
"       <td>",
"        50 to 70",
"       </td>",
"       <td>",
"        50 to 80",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Autoimmune thyroiditis",
"       </td>",
"       <td>",
"        10 to 20",
"       </td>",
"       <td>",
"        80 to 90",
"       </td>",
"       <td>",
"        90 to 100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relatives of patients with autoimmune thyroiditis",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        30 to 50",
"       </td>",
"       <td>",
"        30 to 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Type 1 diabetes",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        30 to 40",
"       </td>",
"       <td>",
"        30 to 40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnant women",
"       </td>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        about 14",
"       </td>",
"       <td>",
"        about 14",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Anti-TSHR Ab: antithyrotropin receptor antibodies; Anti-Tg Ab: antithyroglobulin antibodies; Anti-TPO Ab: antithyroid peroxidase antibodies.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31867=[""].join("\n");
var outline_f31_7_31867=null;
var title_f31_7_31868="Radiation dose to fetus in HL";
var content_f31_7_31868=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F57080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F57080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated radiation dose to the fetus as percentage of the total mantle dose (phantom measurements)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Reference",
"       </td>",
"       <td class=\"subtitle1\">",
"        Energy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Trimester 1",
"       </td>",
"       <td class=\"subtitle1\">",
"        Trimester 2",
"       </td>",
"       <td class=\"subtitle1\">",
"        Trimester 3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zucali et al, 1981*",
"       </td>",
"       <td>",
"        Co60",
"       </td>",
"       <td>",
"        0.21",
"       </td>",
"       <td>",
"        0.45",
"       </td>",
"       <td>",
"        3.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zucali et al, 1981*",
"       </td>",
"       <td>",
"        6 MV",
"       </td>",
"       <td>",
"        0.15",
"       </td>",
"       <td>",
"        0.34",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Covington and Baker, 1969",
"       </td>",
"       <td>",
"        6 MV",
"       </td>",
"       <td>",
"        0.19-0.4",
"       </td>",
"       <td>",
"        0.9-1.4",
"       </td>",
"       <td>",
"        3.7-7.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sharma et al, 1981",
"       </td>",
"       <td>",
"        10 MV",
"       </td>",
"       <td>",
"        0.4&Delta;-0.8&loz;",
"       </td>",
"       <td>",
"        0.6&Delta;-1.1&loz;",
"       </td>",
"       <td>",
"        1.2&Delta;-2.2&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wong et al, 1985",
"       </td>",
"       <td>",
"        10 MV",
"       </td>",
"       <td>",
"        1.3&Delta;-1.4&loz;",
"       </td>",
"       <td>",
"        1.9&Delta;-2.0&loz;",
"       </td>",
"       <td>",
"        4.3&Delta;-5.0&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Woo et al, 1992",
"       </td>",
"       <td>",
"        6 MV",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0.2-0.5",
"       </td>",
"       <td>",
"        0.32-0.42",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Woo et al, 1992",
"       </td>",
"       <td>",
"        Co60",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0.48-0.82",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yahalom, 1990",
"       </td>",
"       <td>",
"        6 MV",
"       </td>",
"       <td>",
"        0.23",
"       </td>",
"       <td>",
"        0.1-0.83",
"       </td>",
"       <td>",
"        3.2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MV: megavolt; Co60: cobalt isotope.",
"     <br>",
"      * Supraclavicular field 11 x 11 cm and opposed mediastinal fields 13 x 13 cm.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Distances from the lower border of the field are slightly smaller than in Sharma et al.",
"       <br>",
"        &Delta; With shielding LMR-13 Toshiba accelerator.",
"        <br>",
"         <span class=\"lozenge\">",
"          &loz;",
"         </span>",
"         Without shielding Cinac 18.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mauch PM, Armitage JO, Diehl V, et al. Hodgkin's Disease, Lippincott Williams &amp; Wilkins, Philadelphia 1999. Copyright &copy; 1999 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31868=[""].join("\n");
var outline_f31_7_31868=null;
var title_f31_7_31869="Lasers in dermatology";
var content_f31_7_31869=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72989&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72989&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinically used lasers in dermatology",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Wavelength (nm)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Laser",
"       </td>",
"       <td class=\"subtitle1\">",
"        Indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        308 (UVB)",
"       </td>",
"       <td>",
"        Excimer (pulsed)",
"       </td>",
"       <td>",
"        Psoriasis, vitiligo, hypopigmentation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        488; 514 (blue-green)",
"       </td>",
"       <td>",
"        Argon (continuous)",
"       </td>",
"       <td>",
"        Telangiectasias, thick PWS in adults, epidermal pigmented lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        504-690 (green-yellow-red)",
"       </td>",
"       <td>",
"        Argon-pumped tunable dye (continuous)",
"       </td>",
"       <td>",
"        Telangiectasias, thick PWS in adults, epidermal pigmented lesions, photodynamic therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        510 (green)",
"       </td>",
"       <td>",
"        Flashlamp-pumped dye (short-pulsed)",
"       </td>",
"       <td>",
"        Epidermal pigmented lesions, red tattoos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        511 (green)",
"       </td>",
"       <td>",
"        Copper vapor/bromide (pseudo-continuous)",
"       </td>",
"       <td>",
"        Epidermal pigmented lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        521; 531 (green)",
"       </td>",
"       <td>",
"        Krypton (continuous)",
"       </td>",
"       <td>",
"        Epidermal pigmented lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        532 (green)",
"       </td>",
"       <td>",
"        KTP (pseudo-continuous)",
"       </td>",
"       <td>",
"        Telangiectasias, thick PWS in adults, epidermal pigmented lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        532 (green)",
"       </td>",
"       <td>",
"        KTP (long-pulsed)",
"       </td>",
"       <td>",
"        Telangiectasias, PWS in adults, epidermal pigmented lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        532 (green)",
"       </td>",
"       <td>",
"        Frequency-doubled Q-switched Nd:YAG (pulsed)",
"       </td>",
"       <td>",
"        Epidermal pigmented lesions, red tattoos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        568 (yellow)",
"       </td>",
"       <td>",
"        Krypton (continuous)",
"       </td>",
"       <td>",
"        Telangiectasias, thick PWS in adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        578 (yellow)",
"       </td>",
"       <td>",
"        Copper vapor/bromide (pseudo-continuous)",
"       </td>",
"       <td>",
"        Telangiectasias, thick PWS in adults",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        585-600 (yellow)",
"       </td>",
"       <td>",
"        Flashlamp-pumped dye (long-pulsed)",
"       </td>",
"       <td>",
"        PWS, PWS in children, telangiectasias, warts, hypertrophic scars, striae",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        694 (red)",
"       </td>",
"       <td>",
"        Q-switched ruby (short-pulsed)",
"       </td>",
"       <td>",
"        Epidermal and dermal pigmented lesions; blue, black and green tattoos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        694 (red)",
"       </td>",
"       <td>",
"        Ruby (long-pulsed)",
"       </td>",
"       <td>",
"        Hair removal, dermal pigmented lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        755 (near infrared)",
"       </td>",
"       <td>",
"        Q-switched alexandrite (short-pulsed)",
"       </td>",
"       <td>",
"        Epidermal and dermal pigmented lesions; blue, black and green tattoos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        755 (near infrared)",
"       </td>",
"       <td>",
"        Alexandrite (long-pulsed)",
"       </td>",
"       <td>",
"        Hair removal, thick vascular lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        800; 810 (near infrared)",
"       </td>",
"       <td>",
"        Diode (long-pulsed)",
"       </td>",
"       <td>",
"        Hair removal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1064 (near infrared)",
"       </td>",
"       <td>",
"        Q-switched Nd:YAG (short-pulsed)",
"       </td>",
"       <td>",
"        Dermal pigmented lesions; blue and black tattoos",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1064 (near infrared)",
"       </td>",
"       <td>",
"        Nd:YAG (pulsed)",
"       </td>",
"       <td>",
"        Hair removal, vascular lesions, leg veins, laser-assisted liposuction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1064 (near infrared)",
"       </td>",
"       <td>",
"        Nd:YAG (continuous)",
"       </td>",
"       <td>",
"        Deep coagulation of tissue",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1320 (near infrared)",
"       </td>",
"       <td>",
"        Nd:YAG (pulsed)",
"       </td>",
"       <td>",
"        Skin rejuvenation, acne scars (subtle)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1450 (near infrared)",
"       </td>",
"       <td>",
"        Diode (pulsed)",
"       </td>",
"       <td>",
"        Sebaceous hyperplasia, acne",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2940 (mid-infrared)",
"       </td>",
"       <td>",
"        Er:YAG (pulsed)",
"       </td>",
"       <td>",
"        Skin resurfacing, tissue ablation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10,600 (far infrared)",
"       </td>",
"       <td>",
"        Carbon dioxide (continuous; pulsed)",
"       </td>",
"       <td>",
"        Coagulation, vaporization and cutting of tissue; skin resurfacing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        500+ (visible to near infrared)",
"       </td>",
"       <td>",
"        Intense pulsed light (pulsed)",
"       </td>",
"       <td>",
"        Vascular lesions, epidermal pigmented lesions, hair removal, photorejuvenation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        810; 940; 980; 1064; 1320 (near infrared)",
"       </td>",
"       <td>",
"        Endovenous Laser Therapy",
"       </td>",
"       <td>",
"        Varicose vein destruction, especially greater saphenous vein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1320; 1440; 1540; 1550",
"       </td>",
"       <td>",
"        Fractionated, non-ablative",
"       </td>",
"       <td>",
"        Photorejuvenation, scars, striae",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2790; 2940; 10,600",
"       </td>",
"       <td>",
"        Fractionated, ablative",
"       </td>",
"       <td>",
"        Photorejuvenation, wrinkles, scars",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31869=[""].join("\n");
var outline_f31_7_31869=null;
var title_f31_7_31870="Septic knee radiograph";
var content_f31_7_31870=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F62141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F62141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Effusion and bony erosion in septic arthritis of the knee",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 291px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This lateral radiograph of the knee demonstrates an effusion in a patient with septic joint. Swelling is most apparent in the suprapatellar region (arrow). Erosion of the tibial articular surface is also apparent (arrowhead), consistent with infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Shahla Modarresi, MD and Cecilia M Jude, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31870=[""].join("\n");
var outline_f31_7_31870=null;
var title_f31_7_31871="Cellulitis with venous insufficiency";
var content_f31_7_31871=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F77986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F77986&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cellulitis with venous insufficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 236px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral venous insufficiency, as demonstrated by edema, venous flairs, and pigment changes on the left leg. The right leg also shows massive pitting edema (thumb mark at arrow) and red inflamed skin, suggesting the presence of cellulitis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Patrick C Alguire, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_7_31871=[""].join("\n");
var outline_f31_7_31871=null;
